Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 578
interventional 454
Observational 115
Registry 9

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 138
Procedure 40
Device 37
Drug|Other 29
Radiation 25
Biological 24
Drug|Procedure 22
Other 16
Biological|Drug 12
Device|Drug 10
Diagnostic Test 8
Drug|Radiation 8
Behavioral 7
Drug|placebo 7
Device|Drug|Procedure 6
Device|Procedure 5
Biological|Procedure 4
Biological|Device 3
Biological|Drug|Procedure 3
Other|Radiation 3
Biological|Other 2
Biological|Other|Procedure 2
Device|Other 2
Diagnostic Test|Drug 2
Diagnostic Test|Procedure 2
Dietary Supplement 2
Drug|Other|placebo 2
Drug|Other|Radiation 2
Drug|placebo|Procedure 2
Drug|Procedure|Radiation 2
Genetic 2
Other|Procedure 2
Behavioral|Dietary Supplement 1
Behavioral|Drug|Genetic|Other|Procedure 1
Behavioral|Drug|Other 1
Behavioral|Other 1
Behavioral|placebo 1
Behavioral|Procedure 1
Biological|Combination Product 1
Biological|Drug|Genetic|Other|Procedure 1
Biological|Drug|Other 1
Biological|placebo 1
Biological|Radiation 1
Combination Product|Drug 1
Device|Diagnostic Test 1
Device|Diagnostic Test|Drug 1
Device|Procedure|Radiation 1
Device|Radiation 1
Dietary Supplement|Drug|Other 1
Drug|Genetic 1
Drug|Genetic|Other 1
Drug|Genetic|Other|Procedure|Radiation 1
Drug|Other|Procedure 1
Other|Procedure|Radiation 1
Procedure|Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 232
China 53
France 17
Canada 16
Korea, Republic of 10
Taiwan 9
Germany 8
Italy 7
NA 7
Netherlands 7
United Kingdom 6
Sweden 5
Belgium 4
Australia 3
Egypt 3
Hong Kong 3
Slovenia 3
Spain 3
Switzerland 3
United States|Germany 3
Austria 2
Poland 2
Singapore 2
United States|Australia|Canada 2
United States|Canada 2
Australia|Hong Kong|Singapore|Taiwan 1
Austria|Bosnia and Herzegovina|Croatia|Germany|India|Italy|Latvia|Poland|Romania|Russian Federation|Serbia|Sweden|Ukraine 1
Austria|France|Germany|Netherlands|Sweden|Switzerland 1
Austria|Germany 1
Austria|Hungary|Switzerland 1
Bangladesh|Indonesia|Korea, Republic of|Myanmar|New Zealand|Philippines|Singapore|Taiwan|Thailand|Vietnam 1
Belgium|Canada|France|Spain|United Kingdom 1
Belgium|Denmark|France|Germany|Hong Kong|Israel|Italy|Korea, Republic of|Portugal|South Africa|Spain|Sweden|Switzerland|Taiwan|Ukraine|United Kingdom 1
Belgium|United Kingdom 1
Belgium|United States|Canada|France|Italy|Korea, Republic of|Singapore|Spain|Taiwan 1
Brazil 1
China|United Kingdom 1
Croatia|Hong Kong|India|Korea, Republic of|Malaysia|Philippines|Poland|Serbia|Singapore|Sweden|Thailand 1
Denmark|Norway|Sweden 1
Finland 1
France|Germany 1
France|Korea, Republic of|Taiwan 1
Hong Kong|Indonesia|Malaysia|New Zealand|Pakistan|Singapore 1
Hong Kong|Singapore|Taiwan 1
India 1
Japan 1
Korea, Republic of|Philippines|Taiwan 1
Lithuania 1
Mongolia 1
Netherlands|Switzerland 1
Norway 1
Singapore|Taiwan|United Kingdom 1
Thailand 1
United States|Argentina|Belgium|Brazil|Canada|China|France|Germany|Greece|Hong Kong|India|Italy|Japan|Korea, Republic of|Mexico|Puerto Rico|Russian Federation|Spain|Taiwan 1
United States|Australia|Belgium|France|Germany|Israel|Italy|New Zealand|Poland|Spain|Switzerland 1
United States|Australia|Canada|Hong Kong|Korea, Republic of 1
United States|Australia|Canada|New Zealand|Puerto Rico 1
United States|Austria|Belgium|Germany|Korea, Republic of|Spain|Switzerland 1
United States|Austria|Canada|Germany|Hong Kong|Italy|Japan|Switzerland|Taiwan 1
United States|Canada|China|Korea, Republic of|Singapore|Taiwan 1
United States|Canada|France|Germany|Hong Kong|Korea, Republic of|Taiwan 1
United States|Canada|Puerto Rico 1
United States|China 1
United States|France|Spain|United Kingdom 1
United States|Japan|Korea, Republic of|Taiwan 1
United States|Singapore 1
United States|Taiwan 1

Sites per Study

Site_count Study_Count
1 320
2 35
3 14
4 12
5 5
6 9
7 4
8 5
9 2
10 3
11 4
12 3
13 1
14 1
15 2
16 2
17 2
19 2
20 2
21 3
23 1
24 1
26 1
28 1
31 1
34 1
37 1
38 1
41 1
42 1
44 1
46 1
51 1
57 1
61 1
66 1
76 1
92 1
111 1
113 1
177 2
295 1

Phase

Phase Study_Count
Phase 2 127
N/A 117
Phase 1 96
Phase 1/Phase 2 46
Phase 3 35
Phase 4 14
Phase 2/Phase 3 11
Early Phase 1 8

Number of Arms

Number_of_Arms Count_of_Studies
1 224
2 130
3 23
4 11
5 1
6 3
14 1
NA 61

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 1.00 4.0000 1.00000 5.00000 3.00000 26.0000 50.0000 30.000
1st Qu. 14.75 24.0000 14.00000 25.00000 25.75000 63.5000 130.0000 58.250
Median 26.50 50.0000 24.00000 40.00000 44.50000 100.0000 208.0000 100.000
Mean 37.25 162.2393 38.78495 54.84091 57.33333 257.1818 236.0303 5886.857
3rd Qu. 40.25 149.0000 43.00000 61.50000 67.25000 162.0000 321.0000 290.000
Max. 108.00 2871.0000 260.00000 300.00000 356.00000 1220.0000 587.0000 80000.000

Trial Group Type

group_type Group_Count
Experimental 470
Active Comparator 80
NA 61
Other 39
No Intervention 25
Placebo Comparator 18
Sham Comparator 2

Intervention Model

intervention_model Study_Count
Single Group Assignment 267
Parallel Assignment 140
NA 34
Sequential Assignment 8
Factorial Assignment 3
Crossover Assignment 2

Primary Purpose

primary_purpose Study_Count
Treatment 363
Diagnostic 39
Prevention 20
Other 11
Supportive Care 8
Health Services Research 3
Screening 3
NA 3
Basic Science 2
Device Feasibility 2

Observational Studies

Studies by Country

Country Study_Count
United States 47
Italy 12
NA 9
China 8
France 5
Germany 3
Netherlands 3
Switzerland 3
United Kingdom 3
Belgium 2
Canada 2
Denmark 2
Israel 2
Korea, Republic of 2
United States|Canada 2
Austria 1
France|Spain|Switzerland 1
Greece 1
Japan 1
Sweden 1
United States|Argentina|Austria|Belgium|Canada|China|Denmark|Egypt|France|Greece|Italy|Japan|Korea, Republic of|Netherlands|Russian Federation|Saudi Arabia|Spain|Sweden|Taiwan|Thailand|Turkey 1
United States|Austria|Belgium|France|Japan|Poland 1
United States|Canada|Puerto Rico|Switzerland 1
United States|France|Germany|New Zealand|Switzerland|United Kingdom 1
United States|Italy|Japan|Singapore|Taiwan 1

Sites per Study

Site_count Study_Count
1 93
2 4
3 5
4 4
5 1
6 1
9 2
10 1
20 1
31 1
37 1
66 1

Enrollment Metrics

Measure Observational
Min 2.0000
1st Qu 56.2500
Median 123.0000
Mean 421.3596
3rd Qu 350.5000
Max 5000.0000

Observation Model

observational_model Study_Count
Cohort 68
Case-Only 16
Other 11
Case-Control 9
NA 7
Case Control 3
Defined Population 1

Time Perspective

time_perspective Study_Count
Prospective 78
Retrospective 26
Cross-Sectional 5
Other 3
NA 2
Longitudinal, Prospective 1

Registries

Studies by Country

Country Study_Count
France 2
Austria|Belgium|Germany|Italy|Netherlands|Spain 1
China 1
Italy 1
NA 1
Netherlands 1
United States 1
United States|France|Germany|Italy|Spain 1

Sites per Study

Site_count Study_Count
1 6
7 1
12 1
70 1

Enrollment Metrics

Measure Registries
Min 40
1st Qu 350
Median 600
Mean 3773
3rd Qu 5000
Max 20000

Registry Model

observational_model Study_Count
Cohort 9

Time Perspective

time_perspective Study_Count
Prospective 8
Other 1

Follow-up

target_duration Study_Count
10 Years 2
1 Year 1
12 Months 1
2 Years 1
24 Months 1
36 Months 1
404 Days 1
5 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT04440943 A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies https://ClinicalTrials.gov/show/NCT04440943 Recruiting Celldex Therapeutics 2022-03-31
NCT03370198 Hepatic Transarterial Administrations of NKR-2 in Patients With Unresectable Liver Metastases From Colorectal Cancer https://ClinicalTrials.gov/show/NCT03370198 Active, not recruiting Celyad Oncology SA 2019-01-15
NCT03338543 PENS or TENS for Pain in Liver Cancer https://ClinicalTrials.gov/show/NCT03338543 Completed Fuda Cancer Hospital, Guangzhou 2018-04-30
NCT03326791 Aspirin in Colorectal Cancer Liver Metastases https://ClinicalTrials.gov/show/NCT03326791 Recruiting Oslo University Hospital 2023-10-31
NCT03310008 Dose Escalation and Dose Expansion Phase I Study to Assess the Safety and Clinical Activity of Multiple Doses of NKR-2 Administered Concurrently With FOLFOX in Colorectal Cancer With Potentially Resectable Liver Metastases https://ClinicalTrials.gov/show/NCT03310008 Active, not recruiting Celyad Oncology SA 2021-05-31
NCT03307811 Endoscopic Ultrasound Guided Liver Biopsy https://ClinicalTrials.gov/show/NCT03307811 Completed AdventHealth 2018-06-19
NCT03299036 Drug-loadable(T-ACE Beads)for Hepatoma Embolization Therapy https://ClinicalTrials.gov/show/NCT03299036 Completed National Cheng-Kung University Hospital 2018-10-16
NCT03264716 Transarterial Chemoembolization by Hepasphere Microspheres for the Treatment of Unresectable Colorectal Liver Metastasis https://ClinicalTrials.gov/show/NCT03264716 Completed National Taiwan University Hospital 2018-01-26
NCT03259867 Combination of TATE and PD-1 Inhibitor in Liver Cancer https://ClinicalTrials.gov/show/NCT03259867 Active, not recruiting Teclison Ltd. 2020-10-30
NCT03239158 Bioinformation Therapy for Liver Cancer https://ClinicalTrials.gov/show/NCT03239158 Completed Fuda Cancer Hospital, Guangzhou 2018-09-02
NCT03223818 The Impact of Fast-track Perioperative Program After Liver Resection in Hong Kong Chinese Patients https://ClinicalTrials.gov/show/NCT03223818 Recruiting Chinese University of Hong Kong 2020-07-01
NCT03223142 Standardization of Multi-modal Tumor Ablation Therapy System https://ClinicalTrials.gov/show/NCT03223142 Recruiting Shanghai Zhongshan Hospital 2019-12-31
NCT03213314 HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies https://ClinicalTrials.gov/show/NCT03213314 Completed University of Edinburgh 2019-03-31
NCT03195699 Oral STAT3 Inhibitor, TTI-101, in Patients With Advanced Cancers https://ClinicalTrials.gov/show/NCT03195699 Recruiting Tvardi Therapeutics, Incorporated 2020-07-31
NCT03183219 Safety and Efficiency of γδ T Cell Against Liver Cancer https://ClinicalTrials.gov/show/NCT03183219 Completed Fuda Cancer Hospital, Guangzhou 2018-01-15
NCT03164382 Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT03164382 Recruiting Sun Yat-sen University 2019-12-31
NCT03159585 To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors https://ClinicalTrials.gov/show/NCT03159585 Completed Zhujiang Hospital 2019-06-04
NCT03151213 Effect of Pregabalin on the Postoperative Analgesia in RFA of Focal Lesions in the Liver https://ClinicalTrials.gov/show/NCT03151213 Recruiting Tanta University 2019-12-31
NCT03146637 Study of Activated CIK Armed With Bispecific Antibody for Advanced Liver Cancer https://ClinicalTrials.gov/show/NCT03146637 Recruiting Benhealth Biopharmaceutical (Shenzhen) Co., Ltd. 2020-12-31
NCT03143270 A Study to Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead Transarterial Chemoembolization in Patients With Liver Cancer https://ClinicalTrials.gov/show/NCT03143270 Recruiting Memorial Sloan Kettering Cancer Center 2022-04-30
NCT03143140 The Effect of Percutaneous Radiofrequency Ablation of Feeding Arterial for Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT03143140 Active, not recruiting Beijing Cancer Hospital 2018-03-31
NCT03135652 Consolidative Radiotherapy for Colorectal Cancer Liver Metastases Receiving Surgery or Radiofrequency Ablation https://ClinicalTrials.gov/show/NCT03135652 Recruiting Wuhan Union Hospital, China 2021-06-01
NCT03132792 AFPᶜ³³²T in Advanced HCC https://ClinicalTrials.gov/show/NCT03132792 Recruiting Adaptimmune 2021-06-30
NCT03127072 Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Unresectable CRLM https://ClinicalTrials.gov/show/NCT03127072 Recruiting Fudan University 2019-12-31
NCT03109262 Yttrium Y 90 Glass Microspheres PET/CT in Imaging Patients With Liver Tumors https://ClinicalTrials.gov/show/NCT03109262 Active, not recruiting Stanford University 2020-02-15
NCT03101475 Synergism of Immunomodulation and Tumor Ablation https://ClinicalTrials.gov/show/NCT03101475 Recruiting European Organisation for Research and Treatment of Cancer - EORTC 2021-08-31
NCT03092895 A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC https://ClinicalTrials.gov/show/NCT03092895 Recruiting Jiangsu HengRui Medicine Co., Ltd. 2018-11-30
NCT03088150 COLLISION Trial - Colorectal Liver Metastases: Surgery vs Thermal Ablation https://ClinicalTrials.gov/show/NCT03088150 Recruiting VU University Medical Center 2022-07-31
NCT03053466 APL-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors https://ClinicalTrials.gov/show/NCT03053466 Active, not recruiting Apollomics (Australia) Pty. Ltd. 2020-02-29
NCT03037437 Sorafenib Induced Autophagy Using Hydroxychloroquine in Hepatocellular Cancer https://ClinicalTrials.gov/show/NCT03037437 Recruiting The University of Texas Health Science Center at San Antonio 2022-04-30
NCT03028311 Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer https://ClinicalTrials.gov/show/NCT03028311 Active, not recruiting M.D. Anderson Cancer Center 2021-01-31
NCT02984566 Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM) https://ClinicalTrials.gov/show/NCT02984566 Recruiting University of Sydney 2021-03-31
NCT02954913 Simultaneous Resection of Colorectal Cancer With Synchronous Liver Metastases https://ClinicalTrials.gov/show/NCT02954913 Recruiting Hamilton Health Sciences Corporation 2020-10-31
NCT02947165 Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies. https://ClinicalTrials.gov/show/NCT02947165 Recruiting Novartis 2021-04-13
NCT02932956 Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP) https://ClinicalTrials.gov/show/NCT02932956 Recruiting Baylor College of Medicine 2022-01-31
NCT02929082 Interest of elastoFRM With Force Measure by MRI on Patients With Hepatocellular Cancer https://ClinicalTrials.gov/show/NCT02929082 Recruiting Assistance Publique - Hôpitaux de Paris 2021-03-31
NCT02156739 Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions https://ClinicalTrials.gov/show/NCT02156739 Recruiting M.D. Anderson Cancer Center 2021-10-31
NCT02893982 High Dose Rate Brachyablation of Primary Liver Lesions https://ClinicalTrials.gov/show/NCT02893982 Active, not recruiting University of Texas Southwestern Medical Center 2021-12-31
NCT02886104 Comparison of Hepatectomy and Local Ablation for Resectable Synchronous and Metachronous Colorectal Liver Metastasis https://ClinicalTrials.gov/show/NCT02886104 Recruiting Sixth Affiliated Hospital, Sun Yat-sen University 2021-07-31
NCT02881554 Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery https://ClinicalTrials.gov/show/NCT02881554 Recruiting University of Washington 2022-06-01
NCT02864485 Living Donor Liver Transplantation for Unresectable Colorectal Cancer Liver Metastases https://ClinicalTrials.gov/show/NCT02864485 Recruiting University Health Network, Toronto 2023-09-30
NCT02853500 Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies https://ClinicalTrials.gov/show/NCT02853500 Recruiting Dana-Farber Cancer Institute 2021-07-31
NCT02850536 CAR-T Hepatic Artery Infusions or Pancreatic Venous Infusions for CEA-Expressing Liver Metastases or Pancreas Cancer https://ClinicalTrials.gov/show/NCT02850536 Active, not recruiting Roger Williams Medical Center 2018-12-31
NCT02849015 Combination of Cryosurgery and NK Immunotherapy for Tumors in Transplanted Liver https://ClinicalTrials.gov/show/NCT02849015 Completed Fuda Cancer Hospital, Guangzhou 2017-07-01
NCT02843802 Combination of Cryosurgery and NK Immunotherapy for Advanced Liver Cancer https://ClinicalTrials.gov/show/NCT02843802 Completed Fuda Cancer Hospital, Guangzhou 2017-07-01
NCT02834780 Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT02834780 Recruiting Eisai Inc. 2020-06-30
NCT02829359 Effects of Antiviral Therapy on HBV Reactivation https://ClinicalTrials.gov/show/NCT02829359 Completed Guangxi Medical University 2015-12-31
NCT02825550 Taiwan ACE Beads for Hepatoma Embolization Therapy https://ClinicalTrials.gov/show/NCT02825550 Completed National Cheng-Kung University Hospital 2016-12-31
NCT02794337 TACE vs TACE+SBRT for Unresectable Hepatocellular Cancer https://ClinicalTrials.gov/show/NCT02794337 Recruiting Tata Memorial Hospital 2022-01-31
NCT02760537 Lay Health Worker Model to Reduce Liver Cancer Disparities in Asian Americans https://ClinicalTrials.gov/show/NCT02760537 Completed Thomas Jefferson University 2014-10-31
NCT02727179 Open vs Laparoscopic Liver Surgery for Colorectal Liver Metastases https://ClinicalTrials.gov/show/NCT02727179 Completed Hospital Universitario Virgen de la Arrixaca 2017-03-31
NCT02716012 First-in-Human Safety and Tolerability Study of MTL-CEBPA in Patients With Advanced Liver Cancer https://ClinicalTrials.gov/show/NCT02716012 Recruiting Mina Alpha Limited 2019-03-31
NCT02687113 Pre-procedure Planning for Radiofrequency Ablation Using CT or MR/US Fusion https://ClinicalTrials.gov/show/NCT02687113 Completed Seoul National University Hospital 2015-01-31
NCT02649868 LC Bead LUMI Radio-Opaque Embolic Beads to Detect and Characterize the Vascularity of Hepatic Tumors During Treatment With Transarterial Embolization (TAE) Alone or Combined With Thermal Ablation https://ClinicalTrials.gov/show/NCT02649868 Enrolling by invitation National Institutes of Health Clinical Center (CC) 2021-12-15
NCT02649153 Effect of Smoked Plum and Chewing Gum on Postoperative Bowel Function Following Hepatic Resection https://ClinicalTrials.gov/show/NCT02649153 Recruiting Guangxi Medical University 2020-12-30
NCT02642978 Robot-assisted Procedure Versus Open Simultaneous Resection of Colorectal Cancer With Liver Metastases https://ClinicalTrials.gov/show/NCT02642978 Recruiting Fudan University 2019-04-01
NCT02632864 Feasibility of High Dose PROton Therapy On Unresectable Primary Carcinoma Of Liver: Prospective Phase II Trial https://ClinicalTrials.gov/show/NCT02632864 Recruiting Samsung Medical Center 2019-10-31
NCT02620228 Identification of Liver Tumours Using BIP - Biopsy System https://ClinicalTrials.gov/show/NCT02620228 Completed Injeq Ltd 2017-12-31
NCT02602327 Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases https://ClinicalTrials.gov/show/NCT02602327 Recruiting University of California, San Francisco 2020-12-31
NCT02597348 Liver Transplantation in Patients With Unresectable Colorectal Liver Metastases Treated by Chemotherapy https://ClinicalTrials.gov/show/NCT02597348 Recruiting Assistance Publique - Hôpitaux de Paris 2027-02-28
NCT02582918 Texas Hepatocellular Carcinoma Consortium (THCCC) Project 5 https://ClinicalTrials.gov/show/NCT02582918 Active, not recruiting University of Texas Southwestern Medical Center 2022-08-31
NCT01967823 T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer https://ClinicalTrials.gov/show/NCT01967823 Completed National Institutes of Health Clinical Center (CC) 2020-04-06
NCT02038296 Different Protocols for Repeated Transarterial Chemoembolization in the Treatment of Patients With Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT02038296 Completed Guangdong Provincial People’s Hospital 2013-03-31
NCT03408665 Stereotactic Body Radiation Therapy (SBRT) Efficiency and Toxicity in Liver Cancer https://ClinicalTrials.gov/show/NCT03408665 Recruiting Centre Oscar Lambret 2026-03-13
NCT02828865 A Clinical Trial Using Irreversible Electroporation for the Treatment of Liver Cancers https://ClinicalTrials.gov/show/NCT02828865 Completed National Taiwan University Hospital 2013-12-18
NCT02571946 Proton Beam Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis https://ClinicalTrials.gov/show/NCT02571946 Recruiting Samsung Medical Center 2019-09-30
NCT02548910 Phlebotomy to Prevent Blood Loss in Major Hepatic Resections https://ClinicalTrials.gov/show/NCT02548910 Completed Ottawa Hospital Research Institute 2018-03-31
NCT02545556 Liver Cancer HepaSphere Combined With Cryosurgery https://ClinicalTrials.gov/show/NCT02545556 Completed Fuda Cancer Hospital, Guangzhou 2016-08-31
NCT02536183 A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors https://ClinicalTrials.gov/show/NCT02536183 Recruiting Children’s National Research Institute 2020-10-31
NCT02524925 Postoperative Stress Response in Patients Following Fast Track vs Conventional Protocol After Hepatectomy or Pancreatectomy https://ClinicalTrials.gov/show/NCT02524925 Completed National and Kapodistrian University of Athens 2015-03-31
NCT02511821 Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing Surgery https://ClinicalTrials.gov/show/NCT02511821 Active, not recruiting City of Hope Medical Center 2020-12-31
NCT02511522 Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases https://ClinicalTrials.gov/show/NCT02511522 Recruiting Canadian Cancer Trials Group 2020-06-30
NCT02510378 Short Course Radiotherapy Combined With Chemotherapy in Stage IV Rectal Cancer With Resectable Liver Metastases https://ClinicalTrials.gov/show/NCT02510378 Recruiting Chinese Academy of Medical Sciences 2020-12-31
NCT02471313 Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization https://ClinicalTrials.gov/show/NCT02471313 Completed National Institutes of Health Clinical Center (CC) 2018-03-07
NCT02461979 The Role of the Vitamin D Receptor Gene Polymorphisms in Hepatocarcinogenesis https://ClinicalTrials.gov/show/NCT02461979 Recruiting Tanta University 2022-12-31
NCT02461966 Evaluation of the Role of Aflatoxin as an Environmental Risk Factor Attributable to Liver Cancer in Nile Delta https://ClinicalTrials.gov/show/NCT02461966 Completed Tanta University 2016-04-30
NCT02449109 Nano Drug Interventional Therapy Using Digital Subtraction Angiography(DSA) for Liver Carcinoma https://ClinicalTrials.gov/show/NCT02449109 Completed Fuda Cancer Hospital, Guangzhou 2016-02-29
NCT02447263 HepaSphere Interventional Therapy Using Digital Subtraction Angiography(DSA) for Liver Cancer https://ClinicalTrials.gov/show/NCT02447263 Completed Fuda Cancer Hospital, Guangzhou 2016-02-29
NCT02425735 Safety and Efficiency of γδ T Cell Against Hepatocellular Liver Cancer https://ClinicalTrials.gov/show/NCT02425735 Completed Fuda Cancer Hospital, Guangzhou 2016-06-30
NCT02424955 Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation https://ClinicalTrials.gov/show/NCT02424955 Recruiting Stanford University 2019-12-14
NCT02416466 CAR-T Hepatic Artery Infusions and Sir-Spheres for Liver Metastases https://ClinicalTrials.gov/show/NCT02416466 Completed Roger Williams Medical Center 2016-11-21
NCT02381561 Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy https://ClinicalTrials.gov/show/NCT02381561 Active, not recruiting National Cancer Institute (NCI) 2018-11-08
NCT02352259 Treatment of Liver Metastases With Electrochemotherapy (ECTJ) Phase II https://ClinicalTrials.gov/show/NCT02352259 Completed Institute of Oncology Ljubljana 2018-10-31
NCT02338778 Safety and Efficacy Study of Mix Vaccine in Hepatocyte Carcinoma Patient https://ClinicalTrials.gov/show/NCT02338778 Completed Fuda Cancer Hospital, Guangzhou 2015-08-31
NCT02329106 Percutaneous Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome https://ClinicalTrials.gov/show/NCT02329106 Recruiting Fuda Cancer Hospital, Guangzhou 2020-12-01
NCT02321202 Omega-3 Fatty Acid-Based Parenteral Nutrition Improves Postoperative Recovery for Cirrhotic Patients With Liver Cancer https://ClinicalTrials.gov/show/NCT02321202 Completed Huazhong University of Science and Technology 2013-09-30
NCT02312817 RCT of Screening Strategies Among Patients at High Risk for Developing HCC in a Safety-net Health System https://ClinicalTrials.gov/show/NCT02312817 Completed University of Texas Southwestern Medical Center 2017-08-31
NCT02292173 Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer https://ClinicalTrials.gov/show/NCT02292173 Active, not recruiting H. Lee Moffitt Cancer Center and Research Institute 2018-12-18
NCT02291133 Treatment of Primary Liver Tumors With Electrochemotherapy (ECT) https://ClinicalTrials.gov/show/NCT02291133 Completed University Medical Centre Ljubljana 2019-09-30
NCT02271646 Ultrasound Guided Thoracic Paravertebral Block for Hepatic Tumors Ablation https://ClinicalTrials.gov/show/NCT02271646 Completed Mahidol University 2015-03-31
NCT02264886 Adaptive MRI-Guided SBRT for Unresectable Primary or Oligometastatic Central Thorax and Abdominal Malignancies https://ClinicalTrials.gov/show/NCT02264886 Completed Washington University School of Medicine 2016-06-30
NCT01522209 Detection Rate of Liver Metastases With Contrast Enhanced Intraoperative Ultrasound Compared to Regular Imaging https://ClinicalTrials.gov/show/NCT01522209 Completed Asklepios Kliniken Hamburg GmbH 2014-12-31
NCT02239900 Ipilimumab and Stereotactic Body Radiation Therapy (SBRT) in Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT02239900 Active, not recruiting M.D. Anderson Cancer Center 2020-08-31
NCT02232490 Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimut-L https://ClinicalTrials.gov/show/NCT02232490 Recruiting Immunitor LLC 2019-11-30
NCT02202317 Follow-up Yttrium-90 Internal Pair Production PET/CT vs Brehmsstrahlung Imaging in Patients With Primary/Metastatic Liver Tumors https://ClinicalTrials.gov/show/NCT02202317 Completed University of Miami 2016-10-31
NCT02201797 Reproducibility and Repeatability of Multifunctional MRI Biomarkers of the Body https://ClinicalTrials.gov/show/NCT02201797 Completed Asan Medical Center 2015-06-30
NCT02192671 HR Versus RFA for HCC in Patients With PHT https://ClinicalTrials.gov/show/NCT02192671 Recruiting Guangxi Medical University 2021-08-31
NCT02191878 Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT02191878 Completed Arbutus Biopharma Corporation 2016-05-31
NCT02191761 Safety and Pharmacokinetics of SM04755 in Subjects With Advanced Colorectal, Gastric, Hepatic, or Pancreatic Cancer https://ClinicalTrials.gov/show/NCT02191761 Completed Samumed LLC 2015-05-20
NCT02185768 Chemoembolisation of Hepatocellular Carcinomas Not Subject to Interventive Care by Idarubicin-loaded Beads - IDASPHERE II https://ClinicalTrials.gov/show/NCT02185768 Completed Federation Francophone de Cancerologie Digestive 2018-05-31
NCT02185443 Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases https://ClinicalTrials.gov/show/NCT02185443 Recruiting University of Sao Paulo 2021-05-31
NCT02181075 Targeted Chemotherapy Using Focused Ultrasound for Liver Tumours https://ClinicalTrials.gov/show/NCT02181075 Completed University of Oxford 2017-03-31
NCT02174549 Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer https://ClinicalTrials.gov/show/NCT02174549 Active, not recruiting Teclison Ltd. 2020-08-31
NCT02172651 Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases https://ClinicalTrials.gov/show/NCT02172651 Recruiting Dana-Farber Cancer Institute 2020-12-31
NCT02145559 A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT02145559 Completed University of Chicago 2016-11-15
NCT02141906 A Pilot Study of “OncozeneTM” Microspheres for Intra-arterial Delivery of Doxorubicin https://ClinicalTrials.gov/show/NCT02141906 Active, not recruiting University of Texas Southwestern Medical Center 2020-06-30
NCT02094625 NAC to Prevent Cisplatin-induced Hearing Loss https://ClinicalTrials.gov/show/NCT02094625 Recruiting Children’s Hospital Los Angeles 2021-01-31
NCT02089919 Cancer Stem Cells Vaccine Therapy in Treating Hepatocellular Cancer Patients https://ClinicalTrials.gov/show/NCT02089919 Completed Fuda Cancer Hospital, Guangzhou 2015-02-28
NCT02088775 PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer https://ClinicalTrials.gov/show/NCT02088775 Active, not recruiting Fox Chase Cancer Center 2016-09-08
NCT02086656 PERIOPERATIVE TREATMENT WITH COI-B (CAPECITABINE, OXALIPLATIN, IRINOTECAN AND BEVACIZUMAB) OF HIGH RISK OR BORDERLINE RESECTABLE COLORECTAL CANCER LIVER METASTASES https://ClinicalTrials.gov/show/NCT02086656 Completed Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 2017-03-30
NCT02082210 A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer https://ClinicalTrials.gov/show/NCT02082210 Completed Eli Lilly and Company 2017-12-05
NCT02076906 MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors https://ClinicalTrials.gov/show/NCT02076906 Recruiting Children’s National Research Institute 2020-10-31
NCT02072486 Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT02072486 Active, not recruiting Roswell Park Cancer Institute 2020-07-03
NCT02072356 Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery https://ClinicalTrials.gov/show/NCT02072356 Recruiting Ohio State University Comprehensive Cancer Center 2027-08-31
NCT02069145 Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular Cancer https://ClinicalTrials.gov/show/NCT02069145 Completed OncoMed Pharmaceuticals, Inc. 2017-05-31
NCT01306058 Sorafenib and TRC105 in Hepatocellular Cancer https://ClinicalTrials.gov/show/NCT01306058 Completed National Institutes of Health Clinical Center (CC) 2016-06-01
NCT02057146 Endoscopic Evaluation of Premalignant Lesions in the Biliary Tract and Pancreatic Ducts https://ClinicalTrials.gov/show/NCT02057146 Completed Karolinska University Hospital 2019-08-22
NCT02042443 Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT02042443 Completed National Cancer Institute (NCI) 2017-01-31
NCT02041065 Waterjet Versus Ultrasound Dissection During Hepatic Transection https://ClinicalTrials.gov/show/NCT02041065 Completed Karolinska University Hospital 2015-02-28
NCT02016391 Effects of Dexmedetomidine During Radiofrequency Ablation of Abdominal Tumours https://ClinicalTrials.gov/show/NCT02016391 Completed Uppsala University Hospital 2014-12-31
NCT03329950 A Study of CDX-1140 as Monotherapy or in Combination in Patients With Advanced Malignancies https://ClinicalTrials.gov/show/NCT03329950 Recruiting Celldex Therapeutics 2021-08-31
NCT03267290 Comparing Diagnostic Accuracy for Liver Tumours Between the Combination of CEUS and CEMRI Versus CECT and CEMRI https://ClinicalTrials.gov/show/NCT03267290 Completed National Taiwan University Hospital 2018-11-29
NCT02015169 Phase II Study of Neoadjuvant XELOX + Lapatinib in HER2(+) Gastric Cancer Patients With Liver Metastasis https://ClinicalTrials.gov/show/NCT02015169 Completed Samsung Medical Center 2017-07-17
NCT02013830 A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver Cancer https://ClinicalTrials.gov/show/NCT02013830 Completed Hoffmann-La Roche 2008-03-31
NCT02010801 Evaluation of Tumor Ablation Effects by Irreversible Electroporation for Patients With Malignant Liver Tumors https://ClinicalTrials.gov/show/NCT02010801 Completed National Taiwan University Hospital 2013-12-31
NCT01936233 Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery https://ClinicalTrials.gov/show/NCT01936233 Recruiting Fudan University 2021-12-31
NCT01906021 Study of New Software Used During Ablations https://ClinicalTrials.gov/show/NCT01906021 Completed National Institutes of Health Clinical Center (CC) 2015-08-01
NCT01899261 Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT01899261 Completed Albert Einstein College of Medicine 2016-05-09
NCT01877187 Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer https://ClinicalTrials.gov/show/NCT01877187 Completed Yale University 2020-02-29
NCT01862718 Fusion Guided Thermal Ablation Combined With External Beam Radiation for Hepatic Neoplasms https://ClinicalTrials.gov/show/NCT01862718 Completed National Institutes of Health Clinical Center (CC) 2017-11-05
NCT01853618 Tremelimumab With Chemoembolization or Ablation for Liver Cancer https://ClinicalTrials.gov/show/NCT01853618 Completed National Institutes of Health Clinical Center (CC) 2017-06-07
NCT02820194 A Trial on SBRT Versus MWA for Inoperable Colorectal Liver Metastases (CLM) https://ClinicalTrials.gov/show/NCT02820194 Recruiting Istituto Clinico Humanitas 2021-02-28
NCT01799044 Pilot-study: Non-thermal Ablation Using Irreversible Electroporation to Treat Colorectal Liver Metastases https://ClinicalTrials.gov/show/NCT01799044 Completed VU University Medical Center 2013-09-30
NCT01785212 The Influence of Two Different Hepatectomy Methods on Transection Speed and Chemokine Release From the Liver https://ClinicalTrials.gov/show/NCT01785212 Completed Medical University of Vienna 2014-12-31
NCT01782573 The Efficacy of Chlorhexidine Gluconate Pre - Disinfection Scrubbing in Preventing Surgical Site Infections for Hepatectomy Patients https://ClinicalTrials.gov/show/NCT01782573 Completed Changhua Christian Hospital 2012-09-30
NCT01775501 Sorafenib + mFOLFOX for Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT01775501 Completed Massachusetts General Hospital 2018-07-31
NCT01766219 CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery https://ClinicalTrials.gov/show/NCT01766219 Completed Wake Forest University Health Sciences 2018-04-30
NCT01754987 A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective https://ClinicalTrials.gov/show/NCT01754987 Completed Thomas Jefferson University 2016-01-31
NCT01749332 A Pilot Study of Perihepatic Phlebotomy During Hepatic Resections https://ClinicalTrials.gov/show/NCT01749332 Completed Memorial Sloan Kettering Cancer Center 2019-12-31
NCT04187937 Feasibility of Ultrasound-based Navigation for Non-anatomical Liver Resections https://ClinicalTrials.gov/show/NCT04187937 Recruiting University Hospital Inselspital, Berne 2020-10-31
NCT01743469 A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers https://ClinicalTrials.gov/show/NCT01743469 Completed Ipsen 2014-12-31
NCT01738217 Assessment of Indocyanine Green as a Near-Infrared Fluorescent Contrast Agent for Image-guided Liver Surgery https://ClinicalTrials.gov/show/NCT01738217 Completed Centre Leon Berard 2015-05-31
NCT01730937 Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer https://ClinicalTrials.gov/show/NCT01730937 Recruiting Radiation Therapy Oncology Group 2024-06-30
NCT01697371 Proton Therapy in the Treatment of Liver Metastases https://ClinicalTrials.gov/show/NCT01697371 Recruiting Loma Linda University 2024-09-30
NCT01666756 Chinese Herbal Formulation PHY906 and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer https://ClinicalTrials.gov/show/NCT01666756 Active, not recruiting City of Hope Medical Center 2020-01-31
NCT01643499 Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies https://ClinicalTrials.gov/show/NCT01643499 Completed University of Chicago 2016-08-28
NCT01640522 Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms https://ClinicalTrials.gov/show/NCT01640522 Completed University of Pittsburgh 2013-12-31
NCT01630239 MR-Guided Laser Ablation of Hepatic Tumors https://ClinicalTrials.gov/show/NCT01630239 Completed Mayo Clinic 2015-03-31
NCT01624285 Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer https://ClinicalTrials.gov/show/NCT01624285 Active, not recruiting Jonsson Comprehensive Cancer Center 2020-07-31
NCT01612325 Radioactive Holmium Microspheres for the Treatment of Unresectable Liver Metastases https://ClinicalTrials.gov/show/NCT01612325 Completed UMC Utrecht 2015-08-31
NCT01596283 Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Liver Resection https://ClinicalTrials.gov/show/NCT01596283 Completed Memorial Sloan Kettering Cancer Center 2016-05-31
NCT01528878 Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases https://ClinicalTrials.gov/show/NCT01528878 Completed UNC Lineberger Comprehensive Cancer Center 2014-08-18
NCT01525069 Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT01525069 Active, not recruiting Washington University School of Medicine 2018-08-08
NCT01522937 A Study of Individualized Stereotactic Body Radiation Therapy (SBRT) for Intrahepatic Cancer https://ClinicalTrials.gov/show/NCT01522937 Completed University of Michigan Rogel Cancer Center 2015-11-30
NCT01502410 Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer https://ClinicalTrials.gov/show/NCT01502410 Completed National Cancer Institute (NCI) 2014-06-30
NCT01497444 Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery https://ClinicalTrials.gov/show/NCT01497444 Completed Alliance for Clinical Trials in Oncology 2016-01-31
NCT01494324 Examinations of Tissue From Ablated Malignant Liver Metastases as Predictors of Outcome https://ClinicalTrials.gov/show/NCT01494324 Recruiting Memorial Sloan Kettering Cancer Center 2020-10-31
NCT01493713 Correlation Between RECIST, Morphologic Response by CT- Histopathologic Response in Hepatic Metastasis Secondary to Colorectal Cancer https://ClinicalTrials.gov/show/NCT01493713 Completed Grupo Espanol Multidisciplinario del Cancer Digestivo 2014-12-08
NCT01456156 Study of Postoperative 3D-CRT/IMRT in Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT01456156 Completed Chinese Academy of Medical Sciences 2017-01-31
NCT01438476 Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-Controlled Analgesia For Liver and/or Pancreas https://ClinicalTrials.gov/show/NCT01438476 Completed M.D. Anderson Cancer Center 2017-10-18
NCT01425879 MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT01425879 Completed National Cancer Institute (NCI) 2013-05-31
NCT01395030 PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection https://ClinicalTrials.gov/show/NCT01395030 Completed Queen’s Medical Centre 2017-05-31
NCT01394497 Use of N-Acetylcysteine During Liver Procurement https://ClinicalTrials.gov/show/NCT01394497 Completed Azienda Ospedaliera di Padova 2009-07-31
NCT01387555 A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib https://ClinicalTrials.gov/show/NCT01387555 Completed Jennerex Biotherapeutics 2011-12-31
NCT01375569 TRC105 for Liver Cancer That Has Not Responded to Sorafenib https://ClinicalTrials.gov/show/NCT01375569 Completed National Institutes of Health Clinical Center (CC) 2014-02-01
NCT01356628 A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer https://ClinicalTrials.gov/show/NCT01356628 Active, not recruiting Thomas Jefferson University 2015-04-09
NCT01347333 Stereotactic Body Radiotherapy for Liver Tumors https://ClinicalTrials.gov/show/NCT01347333 Completed Mercy Research 2016-09-30
NCT04348643 Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer https://ClinicalTrials.gov/show/NCT04348643 Recruiting Chongqing Precision Biotech Co., Ltd 2023-01-31
NCT04295330 Lidocaine Combined With Low Opioid Anesthesia and Analgesia in Patients With Primary Liver Cancer https://ClinicalTrials.gov/show/NCT04295330 Recruiting West China Hospital 2021-01-15
NCT04272619 Liver Cancer Community Education https://ClinicalTrials.gov/show/NCT04272619 Recruiting Fox Chase Cancer Center 2020-08-31
NCT04269499 Real-time Imaging of Holmium Radioembolization: a Feasibility Study https://ClinicalTrials.gov/show/NCT04269499 Recruiting Radboud University 2020-07-31
NCT04242342 Adaptative MR-Guided Stereotactic Body Radiotherapy of Liver Tumors https://ClinicalTrials.gov/show/NCT04242342 Recruiting Centre Georges Francois Leclerc 2025-12-02
NCT04241887 Is Thoracic Paravertebral Block a Better Option Than Conscious Sedation for PRFA of Liver Tumors https://ClinicalTrials.gov/show/NCT04241887 Completed University of Warmia and Mazury 2018-12-12
NCT04218253 Clinical Application of Nutrition Support Package Before Hepatectomy https://ClinicalTrials.gov/show/NCT04218253 Recruiting Tianjin Medical University Cancer Institute and Hospital 2021-09-30
NCT04212286 Comparing the Diagnostic Efficiencies of CEUS and EOB-MRI in Patients With High Risk of HCC https://ClinicalTrials.gov/show/NCT04212286 Recruiting Tianjin Third Central Hospital 2021-12-31
NCT04212273 Diagnostic Efficacies of Sonazoid-CEUS and EOB-MRI in Patients With High Risk of HCC https://ClinicalTrials.gov/show/NCT04212273 Recruiting Tianjin Third Central Hospital 2021-12-24
NCT04212221 MGD013 Monotherapy and Combination With Brivanib Dose Escalation and Expansion Study in Advanced Liver Cancer Patients https://ClinicalTrials.gov/show/NCT04212221 Recruiting Zai Lab (Shanghai) Co., Ltd. 2022-12-31
NCT04204577 The Safety and Efficacy of Thermal Ablation Combined With Apatinib and Carilimub for Advanced Liver Cancer https://ClinicalTrials.gov/show/NCT04204577 Recruiting Chinese PLA General Hospital 2021-11-30
NCT04196465 Phase II Study of Neoadjuvant Immune Checkpoint Inhibitor in Patients With Resectable Gastrointestinal Cancers https://ClinicalTrials.gov/show/NCT04196465 Recruiting Asan Medical Center 2026-09-09
NCT04186234 SBRT for Liver Cancer Before Liver Transplantation https://ClinicalTrials.gov/show/NCT04186234 Recruiting The University of Hong Kong 2020-12-31
NCT04178759 Impact of Chemotherapy and Regenerative Markers of Liver Regeneration After Liver Resection for Liver Metastases https://ClinicalTrials.gov/show/NCT04178759 Recruiting Vilnius University 2022-04-01
NCT04172714 Low-dose Y90 Treatment Planning for HCC https://ClinicalTrials.gov/show/NCT04172714 Recruiting Emory University 2021-06-30
NCT04166240 Measuring and Improving the Safety of Test Result Follow-Up https://ClinicalTrials.gov/show/NCT04166240 Active, not recruiting VA Office of Research and Development 2022-04-01
NCT04163237 Combined Immunotherapy and Targeted Therapy for Advanced Liver Cancer https://ClinicalTrials.gov/show/NCT04163237 Recruiting Guangxi Medical University 2020-10-31
NCT04143516 Tissue Analysis After Thermal Ablation for Colon Cancer Liver Metastases Leading to Immediate Retreatment https://ClinicalTrials.gov/show/NCT04143516 Recruiting Memorial Sloan Kettering Cancer Center 2022-10-31
NCT04134559 Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT04134559 Recruiting Dana-Farber Cancer Institute 2023-01-01
NCT04123340 Intraprocedural Assessment of Ablation Margins Using Computed Tomography Co-registration in Primary Liver Tumor Treatment With Percutaneous Ablation https://ClinicalTrials.gov/show/NCT04123340 Recruiting Leiden University Medical Center 2020-10-01
NCT04106453 Navigated Laparoscopic Microwave Ablation of Tumor Mimics in Pig Liver - an Ex-vivo Trial https://ClinicalTrials.gov/show/NCT04106453 Completed Universitätsklinikum Köln 2020-01-14
NCT04090645 TheraSphere & Treatment of Unresectable Primary or Unresectable Secondary Liver Cancer https://ClinicalTrials.gov/show/NCT04090645 Recruiting Methodist Health System 2025-05-31
NCT04083378 Software-Aided Imaging (Morfeus) for Confirming Tumor Coverage With Ablation in Patients With Liver Tumors, the COVER-ALL Study https://ClinicalTrials.gov/show/NCT04083378 Recruiting M.D. Anderson Cancer Center 2022-12-31
NCT04033107 High Dose Vitamin C Combined With Metformin in the Treatment of Malignant Tumors https://ClinicalTrials.gov/show/NCT04033107 Recruiting Zhongnan Hospital 2022-06-30
NCT04020276 OAR-Based, Dose Escalated SBRT With Real Time Adaptive MRI Guidance for Liver Metastases https://ClinicalTrials.gov/show/NCT04020276 Recruiting University of Wisconsin, Madison 2023-08-01
NCT04008797 A Study of E7386 in Combination With Other Anticancer Drug in Participants With Solid Tumor https://ClinicalTrials.gov/show/NCT04008797 Recruiting Eisai Inc. 2021-03-27
NCT03998033 Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT03998033 Recruiting Eureka Therapeutics Inc. 2022-07-01
NCT03979547 EXALT: EXercise Attenuates Liver Tumors Trial https://ClinicalTrials.gov/show/NCT03979547 Recruiting Milton S. Hershey Medical Center 2021-12-31
NCT03965546 ET 140202 -T Cell Combined With TAE or Sorafenib in the Treatment of Liver Cancer https://ClinicalTrials.gov/show/NCT03965546 Recruiting First Affiliated Hospital Xi’an Jiaotong University 2021-06-30
NCT03949231 Infusion of Toripalimab Via Hepatic Arterial Versus Vein for Immunotherapy of Advanced Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT03949231 Recruiting Second Affiliated Hospital of Guangzhou Medical University 2021-01-01
NCT03942328 Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer https://ClinicalTrials.gov/show/NCT03942328 Recruiting Mayo Clinic 2022-05-01
NCT03895970 Lenvatinib Combined Pembrolizumab in Advanced Hepatobiliary Tumors https://ClinicalTrials.gov/show/NCT03895970 Recruiting Peking Union Medical College Hospital 2020-04-01
NCT03895723 Minimally Invasive Versus Open Liver Resection for Patients With Colorectal Cancer Liver Metastases https://ClinicalTrials.gov/show/NCT03895723 Recruiting Fudan University 2021-04-01
NCT03891654 Dynamic Contrast Enhanced Computed Tomography to Assess Radiation Therapy in Liver Cancer Patients https://ClinicalTrials.gov/show/NCT03891654 Recruiting University of Colorado, Denver 2021-01-31
NCT03888859 ET1402L1-ARTEMISâ„¢2 T Cells in Alpha Fetoprotein (AFP) Expressing Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT03888859 Recruiting First Affiliated Hospital Xi’an Jiaotong University 2019-12-06
NCT03856658 Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases https://ClinicalTrials.gov/show/NCT03856658 Recruiting Spectrum Health Hospitals 2020-04-30
NCT03843229 Clinical Trial of Cinobufacini Combined With Transarterial Chemoembolization (TACE) on Primary Liver Cancer https://ClinicalTrials.gov/show/NCT03843229 Recruiting The First Affiliated Hospital of Dalian Medical University 2020-09-01
NCT03803436 Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver Transplantation https://ClinicalTrials.gov/show/NCT03803436 Recruiting Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 2024-01-31
NCT03787056 Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients https://ClinicalTrials.gov/show/NCT03787056 Recruiting Hospices Civils de Lyon 2026-11-30
NCT03781934 A Study to Evaluate MIV-818 in Patients With Liver Cancer Manifestations https://ClinicalTrials.gov/show/NCT03781934 Recruiting Medivir 2021-12-31
NCT03753789 Ablation Confirmation Study https://ClinicalTrials.gov/show/NCT03753789 Recruiting Ethicon, Inc. 2021-10-29
NCT03744624 Application of 3D Printing in Laparoscopic Surgery of Liver Tumors https://ClinicalTrials.gov/show/NCT03744624 Recruiting Jagiellonian University 2021-12-31
NCT03715517 Spinal Anesthesia For Enhanced Recovery After Liver Surgery https://ClinicalTrials.gov/show/NCT03715517 Recruiting University of Manitoba 2019-11-30
NCT03687853 Application of Intrahepatic Arterial Infusion Chemotherapy for Patients With High Risk of Liver Metastases After Pancreatic Cancer Surgery https://ClinicalTrials.gov/show/NCT03687853 Enrolling by invitation Peking University Third Hospital 2018-12-31
NCT03680508 TSR-022 (Anti-TIM-3 Antibody) and TSR-042 (Anti-PD-1 Antibody) in Patients With Liver Cancer https://ClinicalTrials.gov/show/NCT03680508 Recruiting University of Hawaii 2022-10-31
NCT03651154 Hypovolemic Phlebotomy to Reduce Blood Transfusions in Major Hepatic Resections https://ClinicalTrials.gov/show/NCT03651154 Recruiting Ottawa Hospital Research Institute 2022-10-31
NCT03623464 RCT of Mobile Apps & FitBit v. Usual Care https://ClinicalTrials.gov/show/NCT03623464 Recruiting Weill Medical College of Cornell University 2021-06-30
NCT03594929 Effect of Remote Ischaemic preConditioning on Liver Injury in Patients Undergoing LIVER Resection Surgery https://ClinicalTrials.gov/show/NCT03594929 Recruiting Singapore General Hospital 2019-01-18
NCT03594188 Effects of Anesthetic Methods on Hepatic Cancer Cell Malignancy https://ClinicalTrials.gov/show/NCT03594188 Completed RenJi Hospital 2019-07-31
NCT03592706 Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct Therapy https://ClinicalTrials.gov/show/NCT03592706 Recruiting Ivy Life Sciences, Co., Ltd 2021-02-28
NCT03590119 Intra-arterial Lutetium-177-dotatate for Treatment of Patients With Neuro-endocrine Tumor Liver Metastases https://ClinicalTrials.gov/show/NCT03590119 Recruiting UMC Utrecht 2021-09-01
NCT03586050 Study to Evaluate the Safety and Effectiveness of Microwave Ablation in Patients With Hepatocellular Carcinoma in Korea https://ClinicalTrials.gov/show/NCT03586050 Recruiting Ethicon, Inc. 2020-09-30
NCT03579199 Practical Application of Indocyanine Green Camera in Laparoscopic Liver Surgery https://ClinicalTrials.gov/show/NCT03579199 Recruiting Assistance Publique - Hôpitaux de Paris 2021-03-31
NCT03572582 Transarterial Chemoembolization in Combination With Nivolumab Performed for Intermediate Stage Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT03572582 Recruiting AIO-Studien-gGmbH 2021-12-31
NCT03533582 Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery https://ClinicalTrials.gov/show/NCT03533582 Recruiting Children’s Oncology Group 2025-06-30
NCT03488953 Living Donor Liver Transplantation With Two Stage Hepatectomy for Patients With Isolated, Irresectable Colorectal Liver Metastases https://ClinicalTrials.gov/show/NCT03488953 Recruiting Jena University Hospital 2023-06-30
NCT03484962 Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Liver Cancer https://ClinicalTrials.gov/show/NCT03484962 Recruiting Fuda Cancer Hospital, Guangzhou 2020-05-25
NCT03474822 Plasmodium Immunotherapy for Breast and Liver Cancers https://ClinicalTrials.gov/show/NCT03474822 Recruiting CAS Lamvac Biotech Co., Ltd. 2021-12-31
NCT03441100 TCR-engineered T Cells in Solid Tumors Including NSCLC and HCC Patients https://ClinicalTrials.gov/show/NCT03441100 Recruiting Immatics US, Inc. 2020-09-30
NCT03428477 EPA for Metastasis Trial 2 https://ClinicalTrials.gov/show/NCT03428477 Recruiting University of Leeds 2022-01-31
NCT01264952 Treatment of Liver Metastases With Electrochemotherapy https://ClinicalTrials.gov/show/NCT01264952 Completed Institute of Oncology Ljubljana 2013-03-31
NCT01264705 Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer https://ClinicalTrials.gov/show/NCT01264705 Completed University of Texas Southwestern Medical Center 2018-04-30
NCT01260415 A Study of Perioperative Chemotherapy Plus Panitumumab in Patients With Colorectal Cancer Liver Metastases https://ClinicalTrials.gov/show/NCT01260415 Completed University Health Network, Toronto 2013-06-30
NCT01255007 Comparison of Primovist-enhanced MRI, Diffusion Weighted MRI and Multidetector CT of Colorectal Liver Metastases https://ClinicalTrials.gov/show/NCT01255007 Completed University Health Network, Toronto 2014-07-31
NCT01239381 Individualized Stereotactic Body Radiotherapy of Liver Metastases https://ClinicalTrials.gov/show/NCT01239381 Completed Massachusetts General Hospital 2016-01-31
NCT01219985 Benefits Study of Respiratory-gated Positron Emission Tomography Acquisitions of the Liver https://ClinicalTrials.gov/show/NCT01219985 Completed Centre Hospitalier Universitaire, Amiens 2009-12-31
NCT01218854 A Comparison of Methods for Assisting Needle Angle Selection During Image-guided Tissue Biopsy https://ClinicalTrials.gov/show/NCT01218854 Completed National Institutes of Health Clinical Center (CC) 2016-11-16
NCT01186263 Predictive Value of 99mTc- Albumin Spheres Before 90Y- SIR Therapy https://ClinicalTrials.gov/show/NCT01186263 Completed University of Magdeburg 2011-07-31
NCT01177007 Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors https://ClinicalTrials.gov/show/NCT01177007 Completed Yale University 2014-08-31
NCT01171924 A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer Tumors https://ClinicalTrials.gov/show/NCT01171924 Completed Curis, Inc. 2011-10-31
NCT01164202 Chemoembolization of the Liver With or Without Sunitinib Malate in Treating Patients With Liver Cancer https://ClinicalTrials.gov/show/NCT01164202 Completed Federation Francophone de Cancerologie Digestive 2017-07-31
NCT01149304 Preventive Effect of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid to Radiation Induced Liver Toxicity https://ClinicalTrials.gov/show/NCT01149304 Completed University of Magdeburg 2017-11-15
NCT01120288 A Pilot Study of EZN-2968, an Antisense Oligonucleotide Inhibitor of HIF-1alpha, in Adults With Advanced Solid Tumors With Liver Metastases https://ClinicalTrials.gov/show/NCT01120288 Completed National Institutes of Health Clinical Center (CC) NA
NCT01096914 Radiofrequency Versus Laser Ablation for Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT01096914 Completed Cardarelli Hospital 2012-09-30
NCT01075555 Sorafenib Tosylate With or Without Pravastatin in Treating Patients With Liver Cancer and Cirrhosis https://ClinicalTrials.gov/show/NCT01075555 Completed Federation Francophone de Cancerologie Digestive 2015-09-30
NCT01075399 Study of [F 18]HX4 Positron Emission Tomography (PET) as a Tool to Detect Hypoxia in Tumors https://ClinicalTrials.gov/show/NCT01075399 Completed Siemens Molecular Imaging 2011-05-31
NCT01075113 Sorafenib and Vorinostat in Treating Patients With Advanced Liver Cancer https://ClinicalTrials.gov/show/NCT01075113 Completed Virginia Commonwealth University 2017-02-02
NCT01071941 rRp450-Phase I Trial in Liver Metastases and Primary Liver Tumors https://ClinicalTrials.gov/show/NCT01071941 Recruiting Massachusetts General Hospital 2020-07-31
NCT01061840 Trial of Bi-shRNA-furin and Granulocyte Macrophage Colony Stimulating Factor (GMCSF) Augmented Autologous Tumor Cell Vaccine for Advanced Cancer https://ClinicalTrials.gov/show/NCT01061840 Completed Gradalis, Inc. 2018-12-06
NCT01042041 Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancer https://ClinicalTrials.gov/show/NCT01042041 Completed Abramson Cancer Center of the University of Pennsylvania 2010-12-31
NCT01033240 CS1008- in Combination With Sorafenib Compared to Sorafenib Alone in Subjects With Advanced Liver Cancer https://ClinicalTrials.gov/show/NCT01033240 Completed Daiichi Sankyo, Inc. 2014-11-30
NCT01082224 Contrast-Enhanced CT and MRI in Diagnosing and Staging Liver Cancer Using UNOS Policy https://ClinicalTrials.gov/show/NCT01082224 Active, not recruiting American College of Radiology Imaging Network 2022-12-31
NCT01031784 Radioactive Holmium Microspheres for the Treatment of Liver Metastases https://ClinicalTrials.gov/show/NCT01031784 Completed UMC Utrecht 2011-12-31
NCT01011010 Sorafenib Tosylate and Chemoembolization With Doxorubicin Hydrochloride and Mitomycin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery https://ClinicalTrials.gov/show/NCT01011010 Completed UNC Lineberger Comprehensive Cancer Center 2012-12-31
NCT01010126 Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer https://ClinicalTrials.gov/show/NCT01010126 Completed National Cancer Institute (NCI) 2017-03-13
NCT01008566 Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer https://ClinicalTrials.gov/show/NCT01008566 Completed National Cancer Institute (NCI) 2016-05-31
NCT01005199 Sorafenib Tosylate With or Without Everolimus in Treating Patients With Localized, Unresectable, or Metastatic Liver Cancer https://ClinicalTrials.gov/show/NCT01005199 Completed Swiss Group for Clinical Cancer Research 2013-06-30
NCT00997022 Trial of Sorafenib in Hepatocellular Cancer (HCC) Transplant Patients https://ClinicalTrials.gov/show/NCT00997022 Completed Columbia University 2015-05-31
NCT00987766 Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer https://ClinicalTrials.gov/show/NCT00987766 Completed Vanderbilt-Ingram Cancer Center 2013-07-31
NCT00976898 Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT00976898 Completed Massachusetts General Hospital 2017-03-31
NCT00969410 A Pharmacodynamic Study of AV-299 (Formerly SCH 900105) in Subjects With Advanced Solid Tumors Who Have Liver Metastases https://ClinicalTrials.gov/show/NCT00969410 Completed AVEO Pharmaceuticals, Inc. 2011-03-31
NCT00960557 Safety Study of Increasing Doses of Combretasatin A1 Diphosphate (OXi4503) as Monotherapy in Subjects With Hepatic Tumor Burden https://ClinicalTrials.gov/show/NCT00960557 Completed Mateon Therapeutics 2010-10-31
NCT00957424 Acceptability of Less Harmful Alternatives to Cigarettes https://ClinicalTrials.gov/show/NCT00957424 Completed Roswell Park Cancer Institute 2009-08-31
NCT00956930 Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery https://ClinicalTrials.gov/show/NCT00956930 Completed Northwestern University 2016-06-02
NCT00949182 Sorafenib Tosylate Before and After Hepatic Arterial Chemoembolization With Doxorubicin Hydrochloride and Mitomycin C in Treating Patients With Localized Liver Cancer That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT00949182 Completed Rutgers, The State University of New Jersey 2013-06-30
NCT00941967 Sorafenib With or Without Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Liver Cancer https://ClinicalTrials.gov/show/NCT00941967 Completed Institut du Cancer de Montpellier - Val d’Aurelle 2010-12-31
NCT00923897 Palliative Radiotherapy (RT) for Liver Metastases (Mets) and Hepatocellular Carcinoma (HCC)(COLD 4) https://ClinicalTrials.gov/show/NCT00923897 Completed University Health Network, Toronto 2018-09-26
NCT00922181 Single-probe Microwave Ablation (MWA) of Metastatic Liver Cancer https://ClinicalTrials.gov/show/NCT00922181 Completed University Hospital, Gasthuisberg 2009-04-30
NCT00914615 Stereotactic Body Radiation Therapy (SBRT) in Liver Metastasis (COLD 3) https://ClinicalTrials.gov/show/NCT00914615 Active, not recruiting University Health Network, Toronto 2019-08-16
NCT00902343 Controlled Trial Comparing Nomogram-based Versus Standard Allocation of Acute Normovolemic Hemodilution (ANH) During Hepatic Resection https://ClinicalTrials.gov/show/NCT00902343 Completed Memorial Sloan Kettering Cancer Center 2015-04-30
NCT00888407 Community-based Hepatitis B Interventions for Hmong Adults https://ClinicalTrials.gov/show/NCT00888407 Completed University of California, Davis 2011-08-31
NCT00881751 Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer https://ClinicalTrials.gov/show/NCT00881751 Completed Medical University of South Carolina 2016-05-31
NCT00875615 Cisplatin or Carboplatin and Sorafenib in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery https://ClinicalTrials.gov/show/NCT00875615 Completed University of Miami 2012-06-30
NCT00870558 Iodine I 131 Ethiodized Oil in Preventing Recurrent Cancer in Patients Who Have Undergone Treatment for Liver Cancer https://ClinicalTrials.gov/show/NCT00870558 Completed National Cancer Institute (NCI) 2011-05-31
NCT00869843 Study of Saline Linked Monopolar Surface Radiofrequency (RF) Ablation of Hepatic Tumors https://ClinicalTrials.gov/show/NCT00869843 Completed Washington University School of Medicine 2007-10-31
NCT00869271 Postoperative Folfox4 Only Versus Folfox4 Plus Transhepatic Arterial Chemotherapy (TAC) in the Treatment Unresectable Liver Metastasis of Colorectal Cancer https://ClinicalTrials.gov/show/NCT00869271 Completed Fudan University 2007-12-31
NCT00867321 Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer https://ClinicalTrials.gov/show/NCT00867321 Completed Alliance for Clinical Trials in Oncology 2012-04-30
NCT00866944 Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases https://ClinicalTrials.gov/show/NCT00866944 Completed Amgen Research (Munich) GmbH 2011-07-31
NCT00861783 Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With Hepatoma https://ClinicalTrials.gov/show/NCT00861783 Completed Onconova Therapeutics, Inc. 2011-07-31
NCT00858429 Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver Metastases https://ClinicalTrials.gov/show/NCT00858429 Completed Northwestern University 2014-03-19
NCT00848510 EMD 525797 in Colorectal and Ovarian Cancer Patients With Liver Metastases https://ClinicalTrials.gov/show/NCT00848510 Completed Merck KGaA, Darmstadt, Germany 2013-11-30
NCT00844168 Sorafenib Tosylate in Treating Patients With Liver Cancer Who Have Undergone a Liver Transplant https://ClinicalTrials.gov/show/NCT00844168 Completed University of Washington 2010-06-30
NCT04079049 BreCLIM-2 - A RCT Investigating Local Treatment for Breast Cancer Liver Metastases https://ClinicalTrials.gov/show/NCT04079049 Recruiting Umeå University 2029-12-31
NCT00829413 SonoVue®-Enhanced Ultrasound (US) Versus Unenhanced US for Focal Liver Lesion Characterization https://ClinicalTrials.gov/show/NCT00829413 Completed Bracco Diagnostics, Inc 2013-07-31
NCT00825955 Comparison of Brivanib and Best Supportive Care to Placebo for Treatment of Liver Cancer for Those Subjects Who Have Failed Sorafenib Treatment https://ClinicalTrials.gov/show/NCT00825955 Completed Bristol-Myers Squibb 2011-11-15
NCT00824707 Efficacy and Significance of Antiviral Therapy for Unresectable Hepatitis B Virus-related Primary Liver Cancer https://ClinicalTrials.gov/show/NCT00824707 Completed Eastern Hepatobiliary Surgery Hospital 2010-11-30
NCT00822562 Research on Surgery and Micro-Invasive Treatment in Recurrent Primary Liver Cancer https://ClinicalTrials.gov/show/NCT00822562 Completed Eastern Hepatobiliary Surgery Hospital 2009-01-31
NCT04323618 Investigation of Respiratory-related Tumour Motion in Liver Cancer Patients Undergoing SBRT Using Audiovisual Biofeedback https://ClinicalTrials.gov/show/NCT04323618 Completed University of Sydney 2018-04-30
NCT03926039 Sharing Decision-making Program for HCC Patients Treatment Decisions https://ClinicalTrials.gov/show/NCT03926039 Recruiting National Taipei University of Nursing and Health Sciences 2020-10-31
NCT03889093 Immunologic Effects of Radioembolization of Primary and Secondary Liver Malignancies https://ClinicalTrials.gov/show/NCT03889093 Recruiting University of Minnesota 2020-08-01
NCT03674073 A Study Combining Personalized Neoantigen-based Dendritic Cell Vaccine With Microwave Ablation for the Treatment of Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT03674073 Recruiting Chinese PLA General Hospital 2020-10-15
NCT00813293 Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer https://ClinicalTrials.gov/show/NCT00813293 Completed Dana-Farber Cancer Institute 2013-11-30
NCT04195438 Postoperative Heme Oxygenase Induction and Carbon Monoxide Production as a Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy https://ClinicalTrials.gov/show/NCT04195438 Recruiting University of Maryland, Baltimore 2021-12-31
NCT01516710 Oslo Randomized Laparoscopic Versus Open Liver Resection for Colorectal Metastases Study https://ClinicalTrials.gov/show/NCT01516710 Active, not recruiting Oslo University Hospital 2016-04-30
NCT01373047 CEA-Expressing Liver Metastases Safety Study of Intrahepatic Infusions of Anti-CEA Designer T Cells https://ClinicalTrials.gov/show/NCT01373047 Completed Roger Williams Medical Center 2013-07-31
NCT03963726 Clinical Efficacy of Stereotactic Radiotherapy and Microwave Ablation for Liver Metastases From Colorectal Cancer. https://ClinicalTrials.gov/show/NCT03963726 Recruiting Peking University Third Hospital 2021-05-31
NCT02911961 APAP-CYS Protein Adduct Concentrations in Patients With Liver-Directed Therapy Intended to Treat Hepatic Tumors https://ClinicalTrials.gov/show/NCT02911961 Recruiting Denver Health and Hospital Authority 2020-06-30
NCT02784353 Clinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP Malignancy https://ClinicalTrials.gov/show/NCT02784353 Recruiting Asan Medical Center 2019-12-31
NCT02578602 MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer https://ClinicalTrials.gov/show/NCT02578602 Completed University of Southern California 2014-11-30
NCT02509507 Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Tumors Alone and in Combination With Systemic Pembrolizumab https://ClinicalTrials.gov/show/NCT02509507 Recruiting Amgen 2022-10-25
NCT02044224 Effects of Dexmedetomidine During IRE Procedures for Solid Tumours https://ClinicalTrials.gov/show/NCT02044224 Completed Uppsala University Hospital 2015-09-30
NCT02018107 PET/CT-Assessment of Liver Tumor Ablation https://ClinicalTrials.gov/show/NCT02018107 Completed Dana-Farber Cancer Institute 2018-02-16
NCT01880554 Ultrasound Liver Intraoperative Imaging With SonoVue® https://ClinicalTrials.gov/show/NCT01880554 Completed Institut Bergonié 2016-09-30
NCT03867916 Patient Portal and Navigation Program in Providing Information for Asian American Cancer Patients https://ClinicalTrials.gov/show/NCT03867916 Recruiting University of California, San Francisco 2021-02-28
NCT01180959 Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy https://ClinicalTrials.gov/show/NCT01180959 Active, not recruiting M.D. Anderson Cancer Center 2020-03-01
NCT00790569 Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking https://ClinicalTrials.gov/show/NCT00790569 Completed Butler Hospital 2012-10-31
NCT00788697 SonoVue®-Enhanced Ultrasound Versus Unenhanced US for Focal Liver Lesion Characterization https://ClinicalTrials.gov/show/NCT00788697 Completed Bracco Diagnostics, Inc 2013-07-31
NCT00788125 Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors https://ClinicalTrials.gov/show/NCT00788125 Active, not recruiting City of Hope Medical Center 2023-09-30
NCT00777894 Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT00777894 Completed Swiss Group for Clinical Cancer Research 2014-01-31
NCT00775073 Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001 https://ClinicalTrials.gov/show/NCT00775073 Completed Treiber, Gerhard 2011-01-31
NCT00774501 The Feasibility of Using Anesthesia and Suspended Ventilation to Immobilize Liver Tumors During Radiotherapy https://ClinicalTrials.gov/show/NCT00774501 Completed Memorial Sloan Kettering Cancer Center 2016-02-29
NCT00743678 Neoadjuvant FOLFOX6 + Cetuximab in Patients With Colorectal Cancer and Unresectable Liver Metastasis https://ClinicalTrials.gov/show/NCT00743678 Completed Samsung Medical Center 2012-01-31
NCT00740753 Radiolabeled Glass Beads Used for Treating Patients With Primary Liver Cancer When Surgery is Not an Option https://ClinicalTrials.gov/show/NCT00740753 Enrolling by invitation OHSU Knight Cancer Institute 2025-01-31
NCT00732836 Hepatic Arterial Infusion (HAI) of Abraxane https://ClinicalTrials.gov/show/NCT00732836 Completed M.D. Anderson Cancer Center 2016-01-31
NCT00724503 FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer https://ClinicalTrials.gov/show/NCT00724503 Completed Sirtex Medical 2015-05-31
NCT00716976 Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy https://ClinicalTrials.gov/show/NCT00716976 Completed Children’s Oncology Group 2015-04-30
NCT00706576 Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor https://ClinicalTrials.gov/show/NCT00706576 Completed University of Missouri-Columbia 2013-07-31
NCT00666978 Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking https://ClinicalTrials.gov/show/NCT00666978 Completed University of Kansas Medical Center 2010-06-30
NCT00654160 Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00654160 Completed Mayo Clinic 2010-11-30
NCT00652132 Cisplatin With or Without Sodium Thiosulfate in Treating Young Patients With Stage I, II, or III Childhood Liver Cancer https://ClinicalTrials.gov/show/NCT00652132 Completed University of Birmingham 2017-09-04
NCT00629759 A Study of Recombinant Vaccinia Virus to Evaluate the Safety and Efficacy of a Transdermal Injection Within the Tumor of Patients With Primary or Metastatic Hepatic Carcinoma https://ClinicalTrials.gov/show/NCT00629759 Completed Jennerex Biotherapeutics 2007-07-31
NCT00614913 Proton Beam Therapy for Treatment of Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT00614913 Completed Loma Linda University 2009-02-28
NCT00607828 Stereotactic Radiation Therapy in Treating Patients With Advanced Liver Cancer https://ClinicalTrials.gov/show/NCT00607828 Completed University of Nebraska 2017-02-15
NCT00605722 A Study of Tarceva (Erlotinib) and Avastin (Bevacizumab) in Patients With Advanced or Metastatic Liver Cancer. https://ClinicalTrials.gov/show/NCT00605722 Completed Hoffmann-La Roche 2010-09-30
NCT00604721 Selumetinib in Treating Patients With Locally Advanced or Metastatic Liver Cancer https://ClinicalTrials.gov/show/NCT00604721 Completed National Cancer Institute (NCI) 2012-06-30
NCT00604409 Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced Cancer https://ClinicalTrials.gov/show/NCT00604409 Completed Fox Chase Cancer Center 2014-06-30
NCT00600613 Assess the Feasibility of Cone Beam CT to Localize Liver Metastases Immediately Prior to Radiotherapy https://ClinicalTrials.gov/show/NCT00600613 Completed Memorial Sloan Kettering Cancer Center 2010-10-31
NCT00587067 A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy https://ClinicalTrials.gov/show/NCT00587067 Completed Memorial Sloan Kettering Cancer Center 2016-05-19
NCT00584402 Contrast Sonography for Evaluation of Liver Tumors Prior to Radiofrequency Ablation https://ClinicalTrials.gov/show/NCT00584402 Completed University of California, Davis 2009-03-31
NCT00576199 A Study of Avastin (Bevacizumab) and Transarterial Chemoembolisation (TACE) Treatment in Patients With Liver Cancer https://ClinicalTrials.gov/show/NCT00576199 Completed Hoffmann-La Roche 2011-05-31
NCT00575523 Atropine for Prevention of Dysrhythmias Caused by Percutaneous Ethanol Instillation for Hepatoma Therapy https://ClinicalTrials.gov/show/NCT00575523 Completed Medical University of Vienna NA
NCT00557557 Safety Study of Oxaliplatin and 5-fluorouracil Followed by FUDR for Unresectable Colorectal Liver Metastases https://ClinicalTrials.gov/show/NCT00557557 Completed University of Pittsburgh 2012-03-31
NCT00543777 Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease https://ClinicalTrials.gov/show/NCT00543777 Completed M.D. Anderson Cancer Center 2020-01-13
NCT00539643 Trial of Beads Versus Doxorubicin Eluting Beads for Arterial Embolization of Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT00539643 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-02-28
NCT00539253 Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI. https://ClinicalTrials.gov/show/NCT00539253 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2013-03-31
NCT00537121 Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00537121 Completed Roswell Park Cancer Institute 2012-10-31
NCT00534001 Bupropion in Helping Adults Stop Smoking https://ClinicalTrials.gov/show/NCT00534001 Completed Roswell Park Cancer Institute 2008-05-31
NCT00514228 Sunitinib in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT00514228 Completed Swiss Group for Clinical Cancer Research 2008-08-31
NCT00513461 Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection https://ClinicalTrials.gov/show/NCT00513461 Completed University of California, Irvine 2012-08-31
NCT00507585 Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and Avastin https://ClinicalTrials.gov/show/NCT00507585 Completed M.D. Anderson Cancer Center 2010-01-31
NCT00501605 Phase I Study With AZD2171 in Patients With Advanced Solid Malignant Tumors and Liver Metastases https://ClinicalTrials.gov/show/NCT00501605 Completed AstraZeneca 2005-04-30
NCT00493883 Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors https://ClinicalTrials.gov/show/NCT00493883 Completed Southwestern Regional Medical Center 2011-12-31
NCT00486356 Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer https://ClinicalTrials.gov/show/NCT00486356 Completed University of Nebraska 2010-01-31
NCT00483405 Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer https://ClinicalTrials.gov/show/NCT00483405 Completed UNC Lineberger Comprehensive Cancer Center 2010-02-28
NCT00467194 Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT00467194 Completed National Cancer Centre, Singapore 2011-05-31
NCT00465023 Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer or Hepatic Metastases https://ClinicalTrials.gov/show/NCT00465023 Completed Massachusetts General Hospital 2013-09-30
NCT01099631 IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread https://ClinicalTrials.gov/show/NCT01099631 Completed Masonic Cancer Center, University of Minnesota 2014-01-31
NCT00019630 Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors https://ClinicalTrials.gov/show/NCT00019630 Completed National Cancer Institute (NCI) NA
NCT00441376 A Study of ThermoDoxâ„¢ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver https://ClinicalTrials.gov/show/NCT00441376 Completed Celsion 2008-10-31
NCT00440310 Phase 3 Trial of Litxâ„¢ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases https://ClinicalTrials.gov/show/NCT00440310 Completed Light Sciences Oncology 2011-05-31
NCT00436410 Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer https://ClinicalTrials.gov/show/NCT00436410 Completed National Institutes of Health Clinical Center (CC) NA
NCT00410956 Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery https://ClinicalTrials.gov/show/NCT00410956 Active, not recruiting Memorial Sloan Kettering Cancer Center 2020-07-31
NCT00397384 Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer https://ClinicalTrials.gov/show/NCT00397384 Completed National Cancer Institute (NCI) 2013-06-30
NCT00392366 Laser Interstitial Thermal Therapy Under “Real Time” MRI Guidance for “Minimal Invasive” Treatment of Liver Metastasis https://ClinicalTrials.gov/show/NCT00392366 Completed BioTex, Inc. NA
NCT00376987 Zinc Supplements in Lowering Cadmium Levels in Smokers https://ClinicalTrials.gov/show/NCT00376987 Completed Wake Forest University Health Sciences 2006-10-31
NCT00365508 Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking https://ClinicalTrials.gov/show/NCT00365508 Completed Fox Chase Cancer Center 2009-08-31
NCT00365391 Bevacizumab and Erlotinib in Treating Patients With Advanced Liver Cancer https://ClinicalTrials.gov/show/NCT00365391 Completed National Cancer Institute (NCI) 2008-08-31
NCT00363584 Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT00363584 Completed National Cancer Institute (NCI) 2013-08-31
NCT00361309 SU011248 in Advanced Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT00361309 Completed Massachusetts General Hospital 2007-11-30
NCT00355355 A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC) https://ClinicalTrials.gov/show/NCT00355355 Completed Light Sciences Oncology 2012-09-30
NCT00335829 Bevacizumab and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery https://ClinicalTrials.gov/show/NCT00335829 Completed Yale University 2011-02-28
NCT00327652 Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases https://ClinicalTrials.gov/show/NCT00327652 Completed Anza Therapeutics, Inc. 2008-02-29
NCT00321594 Belinostat in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery https://ClinicalTrials.gov/show/NCT00321594 Completed National Cancer Institute (NCI) 2010-08-31
NCT00307866 Identification of Hepatic Lesions https://ClinicalTrials.gov/show/NCT00307866 Completed Bayer NA
NCT00304135 Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery https://ClinicalTrials.gov/show/NCT00304135 Completed Federation Francophone de Cancerologie Digestive 2012-12-31
NCT00303940 Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors https://ClinicalTrials.gov/show/NCT00303940 Completed National Institutes of Health Clinical Center (CC) NA
NCT00293397 Chemoembolization Using Doxorubicin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery https://ClinicalTrials.gov/show/NCT00293397 Completed Yale University 2011-04-30
NCT00257426 Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer https://ClinicalTrials.gov/show/NCT00257426 Completed UNC Lineberger Comprehensive Cancer Center 2007-02-28
NCT00247676 An International Phase 2 Study Of SU011248 In Patients With Inoperable Liver Cancer https://ClinicalTrials.gov/show/NCT00247676 Completed Pfizer 2008-02-29
NCT00242502 Efficacy and Safety Study of Bevacizumab and Erlotinib to Treat Primary Liver Cancer That Cannot be Removed By Surgery https://ClinicalTrials.gov/show/NCT00242502 Completed M.D. Anderson Cancer Center 2011-10-31
NCT00242086 Comparison of Triphasic CT, PET and MR Tumour With Pathological Findings in Colorectal Cancer Liver Metastases https://ClinicalTrials.gov/show/NCT00242086 Completed University Health Network, Toronto 2010-03-31
NCT00238394 Cediranib Maleate in Treating Patients With Locally Advanced or Metastatic Liver Cancer https://ClinicalTrials.gov/show/NCT00238394 Completed National Cancer Institute (NCI) 2007-03-31
NCT00222664 Qidong Hepatitis B Intervention Study https://ClinicalTrials.gov/show/NCT00222664 Completed University of Oxford NA
NCT00208260 Intensified Chemotherapy in CRC After Resection of Liver Metastases https://ClinicalTrials.gov/show/NCT00208260 Completed Institut du Cancer de Montpellier - Val d’Aurelle NA
NCT00200200 Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer https://ClinicalTrials.gov/show/NCT00200200 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-11-30
NCT00199173 Comparing Hepatic Intra-arterial Injection of Yttrium-90 Microspheres Versus Fluorouracil (5FU) in Colorectal Cancer Metastatic to the Liver Only https://ClinicalTrials.gov/show/NCT00199173 Completed Jules Bordet Institute 2010-01-31
NCT00191412 A Study of Pemetrexed in the Treatment of Patients With Advanced Metastatic Cancer of the Liver https://ClinicalTrials.gov/show/NCT00191412 Completed Eli Lilly and Company NA
NCT00187109 Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy https://ClinicalTrials.gov/show/NCT00187109 Completed St. Jude Children’s Research Hospital 2007-02-28
NCT00178243 Feasibility of Treatment of Cancer Involving the Liver With High Dose Radiation https://ClinicalTrials.gov/show/NCT00178243 Completed University of Rochester NA
NCT00168155 Study of 5-FU + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases From Colorectal Adenocarcinoma https://ClinicalTrials.gov/show/NCT00168155 Completed AHS Cancer Control Alberta 2009-05-31
NCT00153998 Cetuximab in Neoadjuvant Treatment of Non-Resectable Colorectal Liver Metastases (CELIM) https://ClinicalTrials.gov/show/NCT00153998 Completed Technische Universität Dresden 2008-03-31
NCT00152906 Stereotactic Radiotherapy (SRT) Liver (COLD 1) https://ClinicalTrials.gov/show/NCT00152906 Active, not recruiting University Health Network, Toronto 2016-07-31
NCT00149396 Safety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the Liver https://ClinicalTrials.gov/show/NCT00149396 Completed MediGene 2008-10-31
NCT00143403 Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal Cancer https://ClinicalTrials.gov/show/NCT00143403 Completed Pfizer 2008-02-29
NCT00128596 Arsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT00128596 Completed University of Pittsburgh 2005-12-31
NCT00122876 Tumor Ablation With Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC) https://ClinicalTrials.gov/show/NCT00122876 Completed Light Sciences LLC NA
NCT00109954 Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery https://ClinicalTrials.gov/show/NCT00109954 Completed University of Pittsburgh 2005-12-31
NCT00107536 Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT00107536 Completed National Cancer Institute (NCI) 2009-05-31
NCT00101036 Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By Surgery https://ClinicalTrials.gov/show/NCT00101036 Completed National Cancer Institute (NCI) 2009-01-31
NCT00096083 Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer https://ClinicalTrials.gov/show/NCT00096083 Completed Delcath Systems Inc. 2012-08-31
NCT00095992 SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer https://ClinicalTrials.gov/show/NCT00095992 Completed Canadian Cancer Trials Group 2006-09-26
NCT00094003 Study of NS-9 in Patients With Liver Metastases https://ClinicalTrials.gov/show/NCT00094003 Completed NS Pharma, Inc. NA
NCT00093444 Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors https://ClinicalTrials.gov/show/NCT00093444 Completed National Institutes of Health Clinical Center (CC) NA
NCT00004136 Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer https://ClinicalTrials.gov/show/NCT00004136 Completed M.D. Anderson Cancer Center 2006-01-25
NCT00002655 Cryosurgery in Treating Patients With Liver Cancer or Liver Metastases https://ClinicalTrials.gov/show/NCT00002655 Completed University of Colorado, Denver 1999-09-30
NCT00003424 Tamoxifen in Treating Patients With Primary Liver Cancer https://ClinicalTrials.gov/show/NCT00003424 Completed National Cancer Institute (NCI) 2000-06-30
NCT00003557 Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer https://ClinicalTrials.gov/show/NCT00003557 Completed University of Chicago 2000-06-30
NCT00087282 Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer https://ClinicalTrials.gov/show/NCT00087282 Completed National Cancer Institute (NCI) NA
NCT00083785 Study of the Litxâ„¢ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases https://ClinicalTrials.gov/show/NCT00083785 Completed Light Sciences LLC NA
NCT00083226 Doxorubicin and Bortezomib in Treating Patients With Liver Cancer https://ClinicalTrials.gov/show/NCT00083226 Completed National Cancer Institute (NCI) 2011-02-28
NCT00003427 Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00003427 Completed Memorial Sloan Kettering Cancer Center 2002-04-30
NCT00081848 Vaccine Therapy and Radiation to Liver Metastasis in Patients With CEA-Positive Solid Tumors https://ClinicalTrials.gov/show/NCT00081848 Completed National Institutes of Health Clinical Center (CC) 2007-08-23
NCT00004108 DX-8951f in Treating Patients With Liver Cancer https://ClinicalTrials.gov/show/NCT00004108 Completed Daiichi Sankyo, Inc. 2005-04-30
NCT00019474 Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer https://ClinicalTrials.gov/show/NCT00019474 Completed Montefiore Medical Center 2000-08-31
NCT00081094 Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver Cancer https://ClinicalTrials.gov/show/NCT00081094 Completed Washington University School of Medicine 2005-06-30
NCT00007813 Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors https://ClinicalTrials.gov/show/NCT00007813 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2005-02-01
NCT00004248 Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT00004248 Completed Roswell Park Cancer Institute 2000-06-30
NCT00077441 Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer) https://ClinicalTrials.gov/show/NCT00077441 Completed National Cancer Institute (NCI) 2006-06-30
NCT00077142 TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) https://ClinicalTrials.gov/show/NCT00077142 Completed M.D. Anderson Cancer Center 2005-07-31
NCT00076609 Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT00076609 Completed PhytoCeutica NA
NCT00009893 Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer https://ClinicalTrials.gov/show/NCT00009893 Completed Alliance for Clinical Trials in Oncology 2005-01-31
NCT00073905 Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT00073905 Completed Swiss Group for Clinical Cancer Research 2006-06-30
NCT00071994 Gefitinib in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer) https://ClinicalTrials.gov/show/NCT00071994 Completed National Cancer Institute (NCI) 2005-05-31
NCT00004074 Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu https://ClinicalTrials.gov/show/NCT00004074 Completed National Cancer Institute (NCI) 2009-02-28
NCT00003907 Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver https://ClinicalTrials.gov/show/NCT00003907 Completed Eastern Cooperative Oncology Group 2011-05-31
NCT00005629 Vaccine Therapy in Treating Patients With Liver Cancer https://ClinicalTrials.gov/show/NCT00005629 Completed Jonsson Comprehensive Cancer Center 2002-05-31
NCT00068068 Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metastases https://ClinicalTrials.gov/show/NCT00068068 Completed Light Sciences LLC NA
NCT00003912 Chemotherapy in Treating Children With Liver Cancer https://ClinicalTrials.gov/show/NCT00003912 Completed National Cancer Institute (NCI) NA
NCT00033462 Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer https://ClinicalTrials.gov/show/NCT00033462 Completed National Cancer Institute (NCI) 2006-11-30
NCT00059865 Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer https://ClinicalTrials.gov/show/NCT00059865 Completed Alliance for Clinical Trials in Oncology 2007-02-28
NCT00058487 Epirubicin and Thalidomide in Treating Patients With Liver Cancer https://ClinicalTrials.gov/show/NCT00058487 Completed National Cancer Institute (NCI) NA
NCT00057980 Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT00057980 Completed Northwestern University 2007-02-28
NCT00055692 Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer https://ClinicalTrials.gov/show/NCT00055692 Completed National Cancer Institute (NCI) 2008-01-31
NCT00054262 T900607 in Treating Patients With Unresectable Liver Cancer https://ClinicalTrials.gov/show/NCT00054262 Completed National Cancer Institute (NCI) 2004-03-31
NCT00041275 Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery https://ClinicalTrials.gov/show/NCT00041275 Completed National Cancer Institute (NCI) 2007-06-30
NCT00052364 Oxaliplatin in Treating Patients With Liver Cancer https://ClinicalTrials.gov/show/NCT00052364 Completed National Cancer Institute (NCI) 2006-01-31
NCT00049322 Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery https://ClinicalTrials.gov/show/NCT00049322 Completed Jonsson Comprehensive Cancer Center 2012-02-29
NCT00047346 Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction https://ClinicalTrials.gov/show/NCT00047346 Completed National Cancer Institute (NCI) 2005-12-31
NCT00047229 Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) https://ClinicalTrials.gov/show/NCT00047229 Completed University Health Network, Toronto 2009-01-31
NCT00040898 Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed https://ClinicalTrials.gov/show/NCT00040898 Completed Memorial Sloan Kettering Cancer Center 2006-01-31
NCT00036959 ABT-751 in Treating Young Patients With Refractory Solid Tumors https://ClinicalTrials.gov/show/NCT00036959 Completed National Institutes of Health Clinical Center (CC) 2010-02-28
NCT00031681 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) https://ClinicalTrials.gov/show/NCT00031681 Completed National Cancer Institute (NCI) 2011-01-31
NCT00030498 Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction https://ClinicalTrials.gov/show/NCT00030498 Completed National Cancer Institute (NCI) 2007-07-31
NCT00030108 Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven’t Responded to Therapy https://ClinicalTrials.gov/show/NCT00030108 Completed National Institutes of Health Clinical Center (CC) 2010-03-31
NCT00030082 Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver Cancer https://ClinicalTrials.gov/show/NCT00030082 Completed National Cancer Institute (NCI) NA
NCT00028496 Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer https://ClinicalTrials.gov/show/NCT00028496 Completed National Cancer Institute (NCI) 2005-11-30
NCT00027534 Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer https://ClinicalTrials.gov/show/NCT00027534 Completed Duke University 2007-10-31
NCT00024258 Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors https://ClinicalTrials.gov/show/NCT00024258 Completed Memorial Sloan Kettering Cancer Center 2009-05-31
NCT00022334 Vaccine Therapy in Treating Patients With Liver Cancer https://ClinicalTrials.gov/show/NCT00022334 Completed Jonsson Comprehensive Cancer Center 2004-12-31
NCT00021047 Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor https://ClinicalTrials.gov/show/NCT00021047 Completed National Institutes of Health Clinical Center (CC) NA
NCT00020150 Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors https://ClinicalTrials.gov/show/NCT00020150 Completed National Cancer Institute (NCI) NA
NCT00019786 Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases https://ClinicalTrials.gov/show/NCT00019786 Completed National Institutes of Health Clinical Center (CC) NA
NCT00019513 Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas https://ClinicalTrials.gov/show/NCT00019513 Completed National Institutes of Health Clinical Center (CC) NA
NCT00019331 Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors https://ClinicalTrials.gov/show/NCT00019331 Completed National Cancer Institute (NCI) NA
NCT00012324 Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer https://ClinicalTrials.gov/show/NCT00012324 Completed National Cancer Institute (NCI) NA
NCT00006016 Thalidomide and Chemoembolization With Doxorubicin in Treating Patients With Liver Cancer That Cannot be Removed by Surgery https://ClinicalTrials.gov/show/NCT00006016 Completed National Cancer Institute (NCI) 2005-04-30
NCT00006010 Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer https://ClinicalTrials.gov/show/NCT00006010 Completed Alliance for Clinical Trials in Oncology 2004-05-31
NCT00006006 Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed https://ClinicalTrials.gov/show/NCT00006006 Completed National Cancer Institute (NCI) 2005-03-31
NCT00003994 Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer https://ClinicalTrials.gov/show/NCT00003994 Completed Children’s Oncology Group 2007-10-31
NCT00002608 Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors https://ClinicalTrials.gov/show/NCT00002608 Completed National Cancer Institute (NCI) NA
NCT00002515 Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer https://ClinicalTrials.gov/show/NCT00002515 Completed Memorial Sloan Kettering Cancer Center 2005-04-30
NCT00001587 A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver https://ClinicalTrials.gov/show/NCT00001587 Completed National Institutes of Health Clinical Center (CC) NA
NCT00041808 Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver https://ClinicalTrials.gov/show/NCT00041808 Completed FeRx NA
NCT00717756 Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial https://ClinicalTrials.gov/show/NCT00717756 Completed Brown University 2013-12-31
NCT00639509 IMC-A12 in Treating Patients With Advanced Liver Cancer https://ClinicalTrials.gov/show/NCT00639509 Completed National Cancer Institute (NCI) 2011-02-28
NCT00608361 Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery https://ClinicalTrials.gov/show/NCT00608361 Completed National Cancer Institute (NCI) 2014-08-31
NCT00001576 A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver https://ClinicalTrials.gov/show/NCT00001576 Completed National Institutes of Health Clinical Center (CC) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03297255 Primary Liver Cancer Cohort of South China https://ClinicalTrials.gov/show/NCT03297255 Recruiting Sun Yat-sen University 2025-12-31
NCT03405909 Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter Study https://ClinicalTrials.gov/show/NCT03405909 Recruiting University Hospital Erlangen 2020-02-29
NCT03401814 Imaging Response to Immunotherapy and Radiation Therapy in Patients With Liver Metastases https://ClinicalTrials.gov/show/NCT03401814 Recruiting Mayo Clinic 2021-05-31
NCT03347162 Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer https://ClinicalTrials.gov/show/NCT03347162 Recruiting Rigshospitalet, Denmark 2021-12-31
NCT03300414 Biologic Basis of Liver Cancer From Chronic Hepatitis B https://ClinicalTrials.gov/show/NCT03300414 Completed University of California, Davis 2018-12-14
NCT03295500 On the Cyberknife Dose Fraction of Liver Cancer Treatment https://ClinicalTrials.gov/show/NCT03295500 Recruiting Beijing 302 Hospital 2020-10-01
NCT03289273 Observational Study to Evaluate, Under Real-world Practice Conditions, the Safety and Effectiveness of Regorafenib in Patients Diagnosed With Unresectable Hepatocellular Carcinoma (uHCC) https://ClinicalTrials.gov/show/NCT03289273 Active, not recruiting Bayer 2022-02-01
NCT03253536 Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT03253536 Recruiting Ludwig-Maximilians - University of Munich 2022-07-10
NCT03171428 Hepatectomy With or Without the Thoraco-abdominal Approach https://ClinicalTrials.gov/show/NCT03171428 Completed University of Milan 2013-12-31
NCT03153332 Value of 3D Printing for Comprehension of Liver Surgical Anatomy https://ClinicalTrials.gov/show/NCT03153332 Completed Guangzhou Women and Children’s Medical Center 2018-01-10
NCT03133286 Radiotherapy Assessments During Intervention ANd Treatment (RADIANT) https://ClinicalTrials.gov/show/NCT03133286 Recruiting DxTerity Diagnostics 2019-09-06
NCT02985034 Safety Margin Assessment After RFA Using the Registration of Pre-ablation MRI and Post-ablation CT https://ClinicalTrials.gov/show/NCT02985034 Completed Seoul National University Hospital 2011-09-30
NCT02838836 Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers https://ClinicalTrials.gov/show/NCT02838836 Recruiting University of Missouri-Columbia 2019-06-30
NCT02781935 Diffusion-Weighted MRI for Liver Metastasis https://ClinicalTrials.gov/show/NCT02781935 Recruiting European Organisation for Research and Treatment of Cancer - EORTC 2021-11-30
NCT02761356 The Added Value of Hybrid Functional Anatomical Imaging PET-CT and SPECT-CT in Patients Treated With Y-90 SIRT for Liver Malignancies https://ClinicalTrials.gov/show/NCT02761356 Completed Tel-Aviv Sourasky Medical Center 2015-08-31
NCT02722395 Magnetic Resonance Imaging (MRI) Solely For Liver Stereotactic Body Radiation Therapy (SBRT) https://ClinicalTrials.gov/show/NCT02722395 Completed Duke University 2017-02-01
NCT02616692 HCC Patient Preferences in Japan https://ClinicalTrials.gov/show/NCT02616692 Completed Bayer 2016-10-07
NCT02615665 Intratumoral CD3+ and NKp46+ Cells in Colorectal Liver Metastases https://ClinicalTrials.gov/show/NCT02615665 Completed University of Milan 2015-08-31
NCT00034216 Collection of Blood From Patients With Cancer https://ClinicalTrials.gov/show/NCT00034216 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT02557724 Mobilization of Mesenchymal Stem Cells During Liver Transplantation https://ClinicalTrials.gov/show/NCT02557724 Completed Rutgers, The State University of New Jersey 2017-07-31
NCT02489838 Lung Dose in Patients Treated With Yttrium-90 for Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT02489838 Completed University of Rochester 2019-08-07
NCT02456285 Colorectal Cancer With Liver-limited Synchronous Metastases: an Inception Cohort Study of Standardised Care Pathways https://ClinicalTrials.gov/show/NCT02456285 Active, not recruiting Manchester University NHS Foundation Trust 2020-08-31
NCT02454686 Fibroscan Predicts Complications After Hepatectomy https://ClinicalTrials.gov/show/NCT02454686 Completed University of Milan 2014-10-31
NCT02416635 The Detection of Circulating Tumor Cells (CTCs) in Patients With Liver Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment https://ClinicalTrials.gov/show/NCT02416635 Completed Fuda Cancer Hospital, Guangzhou 2015-12-31
NCT02404909 Inferior Vena Cava Index in Patients Undergoing Liver Resection https://ClinicalTrials.gov/show/NCT02404909 Completed University of Milan 2014-12-31
NCT02399995 Health Related Quality of Life Following Hepatectomy for Colorectal Liver Metastasis: Global and Disease Specific Changes Over Time https://ClinicalTrials.gov/show/NCT02399995 Recruiting Memorial Sloan Kettering Cancer Center 2021-03-31
NCT02391207 Hepatic Vein-sparing Hepatectomy for Colorectal Liver Metastases at the Caval Confluence https://ClinicalTrials.gov/show/NCT02391207 Completed University of Milan 2012-12-31
NCT02331641 Multiple Minor Hepatectomies Versus Major or Extended Hepatectomies for Colorectal Liver Metastases. https://ClinicalTrials.gov/show/NCT02331641 Completed University of Milan 2014-11-30
NCT02226666 Physiologic Assessment Following Gadoxetic Acid and Gadobenate Dimeglumine Administration https://ClinicalTrials.gov/show/NCT02226666 Completed University of Michigan 2015-12-31
NCT02119065 Pilot Study to Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT https://ClinicalTrials.gov/show/NCT02119065 Active, not recruiting Ohio State University Comprehensive Cancer Center 2020-12-31
NCT02073435 A2ALL-Patients Safety System Improvements in Living Donor Liver Transplantation https://ClinicalTrials.gov/show/NCT02073435 Completed Northwestern University 2015-05-31
NCT01286428 Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures https://ClinicalTrials.gov/show/NCT01286428 Completed Pathfinder Therapeutics 2012-02-29
NCT01283802 Intraoperative Cholangio-Ultrasound in Resective Liver Surgery https://ClinicalTrials.gov/show/NCT01283802 Completed University of Milan NA
NCT01929902 Evaluation of Efficacy and Accuracy of Aquamantys Device in General Surgery https://ClinicalTrials.gov/show/NCT01929902 Completed Atrium Health 2014-01-31
NCT01895673 PET-MRI After Radiofrequency Ablation (RFA) or Microwave Ablation (MWA) https://ClinicalTrials.gov/show/NCT01895673 Completed VU University Medical Center 2016-06-30
NCT01786980 The Methylation Phenotype Screening and Determination Mode Study of Liver Cancer Prognosis Related Gene https://ClinicalTrials.gov/show/NCT01786980 Completed Eastern Hepatobiliary Surgery Hospital 2015-12-31
NCT01774643 A Study of Pancreatic Cancer in Xenografts From Liver Metastases https://ClinicalTrials.gov/show/NCT01774643 Active, not recruiting University Health Network, Toronto 2015-04-30
NCT01736813 CCR5-blockade in Metastatic Colorectal Cancer https://ClinicalTrials.gov/show/NCT01736813 Completed National Center for Tumor Diseases, Heidelberg 2013-12-31
NCT01683357 Prognosis of One-stage Hepatectomy for Bilobar Colorectal Metastases https://ClinicalTrials.gov/show/NCT01683357 Completed University of Milan 2012-03-31
NCT01657383 Surgical Outcomes Database For Faculty of Hepatopancreatic Biliary Surgery https://ClinicalTrials.gov/show/NCT01657383 Completed Atrium Health 2016-12-31
NCT01627808 Fluid Optimization in Liver Surgery https://ClinicalTrials.gov/show/NCT01627808 Completed Catholic University of the Sacred Heart 2012-02-29
NCT01619475 Adult-to-Adult Living Donor Transplant Cohort Study https://ClinicalTrials.gov/show/NCT01619475 Completed Arbor Research Collaborative for Health 2014-08-31
NCT01565811 Prospective Phase II Trial on Prophylactic Perihepatic Lymphadenectomy in Patients With Colorectal Cancer With Liver Metastasis https://ClinicalTrials.gov/show/NCT01565811 Completed Gachon University Gil Medical Center 2012-03-31
NCT01539993 Prospective Liver Study https://ClinicalTrials.gov/show/NCT01539993 Completed Emory University 2014-01-31
NCT01526200 Contrast-Enhanced Intraoperative Ultrasound During Liver Surgery for Colorectal Cancer Liver Metastases https://ClinicalTrials.gov/show/NCT01526200 Completed University of Milan 2011-03-31
NCT01465425 Extracolonic Findings on Computed Tomography (CT) Colonography https://ClinicalTrials.gov/show/NCT01465425 Enrolling by invitation American College of Radiology Imaging Network 2019-12-31
NCT01457599 Computertomography-guided Wire Marking of the Liver https://ClinicalTrials.gov/show/NCT01457599 Completed Medical University of Graz 2016-08-31
NCT01423734 The Reproducibility Of Diffusion Weighted Magnetic Resonance Imaging For Neuroendocrine Tumor Liver Metastases https://ClinicalTrials.gov/show/NCT01423734 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-08-31
NCT01416714 Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy https://ClinicalTrials.gov/show/NCT01416714 Recruiting University of Chicago 2025-01-31
NCT01411579 Use of DwI-MR to Predict Chemotherapy Response of Liver Metastases and Hepatocarcinoma https://ClinicalTrials.gov/show/NCT01411579 Completed University of Florence 2012-02-29
NCT01403727 Electromagnetic Tracking of Devices During Biopsy Procedures https://ClinicalTrials.gov/show/NCT01403727 Completed Philips Healthcare 2013-04-30
NCT01336881 Biomarkers in Tissue Samples From Young Patients With Liver Cancer https://ClinicalTrials.gov/show/NCT01336881 Completed Children’s Oncology Group 2011-07-31
NCT00451022 Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies https://ClinicalTrials.gov/show/NCT00451022 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT04348838 Prospective Cohort of Patients With Hepatocellular Carcinoma in France https://ClinicalTrials.gov/show/NCT04348838 Recruiting Centre Hospitalier Universitaire, Amiens 2027-09-30
NCT04315883 Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors https://ClinicalTrials.gov/show/NCT04315883 Recruiting Nemours Children’s Clinic 2029-03-01
NCT04264754 Characterization of Methylation Patterns in Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT04264754 Recruiting Nucleix Ltd. 2024-12-31
NCT04182386 Scandinavian Cohort Study for Optimal Use of Portal Vein Embolization https://ClinicalTrials.gov/show/NCT04182386 Recruiting Karolinska University Hospital 2021-12-31
NCT04107766 NOLA (NeuWave Observational Liver Ablation) Registry https://ClinicalTrials.gov/show/NCT04107766 Recruiting Ethicon, Inc. 2026-12-31
NCT04072224 Evaluation of the Reproducibility of Ablation Volumes at One Month After Microwave Treatment Compared to the Manufacturer’s Abacus: on the Kidney, Liver and Lung https://ClinicalTrials.gov/show/NCT04072224 Recruiting Centre Hospitalier Universitaire de NÄ«mes 2020-10-23
NCT03995459 Deportalization, Venous Deprivation, Venous Congestion https://ClinicalTrials.gov/show/NCT03995459 Completed University Hospital, Montpellier 2019-04-30
NCT03981497 Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms https://ClinicalTrials.gov/show/NCT03981497 Recruiting IRCCS San Raffaele 2024-02-28
NCT03959800 Molecular Basis of Pediatric Liver Cancer https://ClinicalTrials.gov/show/NCT03959800 Recruiting University of Pittsburgh 2028-06-30
NCT03888638 The Role of Tumor-associated Macrophages in Colorectal Liver Metastases https://ClinicalTrials.gov/show/NCT03888638 Completed Humanitas Clinical and Research Center 2017-12-31
NCT03732235 TACE Associated to Systemic Bevacizumab for the Treatment of Refractory Liver Metastases From Colorectal Cancer https://ClinicalTrials.gov/show/NCT03732235 Recruiting International Group of Endovascular Oncology 2021-10-31
NCT03723304 The Intention-to-treat Effect of Bridge Therapies in the Setting of Milan-in Patients https://ClinicalTrials.gov/show/NCT03723304 Completed European Hepatocellular Cancer Liver Transplant Group 2018-10-15
NCT03698643 Impact of New Interventional Imaging Modality Use on Patient Radiation Exposure in Transarterial Chemoembolization https://ClinicalTrials.gov/show/NCT03698643 Completed University Hospital, Montpellier 2018-04-30
NCT03694600 Clinical Trial for the IvyGene Liver Cancer Test https://ClinicalTrials.gov/show/NCT03694600 Recruiting Laboratory for Advanced Medicine, Indiana 2020-04-28
NCT03689231 Volumetric Imaging Follow up of Patients With Liver Metastases of Small Intestinal Neuroendocrine Tumors (NETs). https://ClinicalTrials.gov/show/NCT03689231 Active, not recruiting Hospices Civils de Lyon 2018-08-30
NCT03679039 A Model for Predicting the Efficacy of Conversion Therapy for Patients With Colorectal Cancer Liver Metastases by the Detection of 5-hydroxymethylcytosine (5-hmC) in Plasma Cell-free DNA https://ClinicalTrials.gov/show/NCT03679039 Recruiting Fudan University 2019-03-31
NCT03645655 PIVKA-II Combined With Alpha-Fetoprotein for Diagnostic and Prognostic Value of Hepatic Tumors in Infants https://ClinicalTrials.gov/show/NCT03645655 Recruiting Shanghai Children’s Medical Center 2020-12-31
NCT03630978 Impact of Sarcopenia on Postoperative Outcomes of Patients Undergoing Liver Resection https://ClinicalTrials.gov/show/NCT03630978 Completed San Camillo Hospital, Rome 2019-12-20
NCT03595345 A Worldwide Score for Hepatocellular Cancer and Liver Transplantation https://ClinicalTrials.gov/show/NCT03595345 Completed European Hepatocellular Cancer Liver Transplant Group 2018-10-15
NCT03585166 Nursing Fro Laparoscopic vs. Open Hepatectomy https://ClinicalTrials.gov/show/NCT03585166 Recruiting Wuhan Union Hospital, China 2023-10-31
NCT03577067 Complicated Outcome Prediction After Liver Resection https://ClinicalTrials.gov/show/NCT03577067 Completed University of Milan 2017-03-31
NCT03562234 The CLiFF Study: Change in Liver Function and Fat in Pre-operative Chemotherapy for Colorectal Liver Metastases https://ClinicalTrials.gov/show/NCT03562234 Recruiting University of Manchester 2020-02-29
NCT03551951 Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow https://ClinicalTrials.gov/show/NCT03551951 Recruiting University of Missouri-Columbia 2022-06-30
NCT03500757 Intra-procedural 360-degree Display for Performing Percutaneous Liver Tumor Ablation https://ClinicalTrials.gov/show/NCT03500757 Enrolling by invitation Case Comprehensive Cancer Center 2020-10-01
NCT03474354 DC Bead LUMI (TM) Loaded With Doxorubicin for Intermediate Hepatocellular Carcinoma (HCC) https://ClinicalTrials.gov/show/NCT03474354 Recruiting University of Athens 2019-12-30
NCT03432806 A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors https://ClinicalTrials.gov/show/NCT03432806 Recruiting Memorial Sloan Kettering Cancer Center 2020-11-30
NCT01238666 Evaluation of a Minimally Invasive Image-Guided Surgery System for Hepatic Ablation Procedures https://ClinicalTrials.gov/show/NCT01238666 Completed Pathfinder Therapeutics 2012-02-29
NCT01237990 Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures https://ClinicalTrials.gov/show/NCT01237990 Completed Pathfinder Therapeutics 2011-10-31
NCT01234701 Agreement Among Expert Radiologists in Diagnosing Primary Liver Tumors by Magnetic Resonance Imaging (MRI) https://ClinicalTrials.gov/show/NCT01234701 Completed University of Zurich 2012-05-31
NCT01043523 Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions. https://ClinicalTrials.gov/show/NCT01043523 Completed Bayer 2013-04-30
NCT00960609 Communicating Veins Between Adjacent Hepatic Veins: an Intra-operative Ultrasound Study https://ClinicalTrials.gov/show/NCT00960609 Completed University of Milan NA
NCT00950144 Studying Pain and Symptom Distress in Patients With Advanced Colon Cancer, Rectal Cancer, Pancreatic Cancer, or Liver Cancer https://ClinicalTrials.gov/show/NCT00950144 Completed City of Hope Medical Center 2010-10-31
NCT00913757 A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area https://ClinicalTrials.gov/show/NCT00913757 Completed National Institutes of Health Clinical Center (CC) 2020-05-01
NCT00900094 UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer https://ClinicalTrials.gov/show/NCT00900094 Completed University of Michigan Rogel Cancer Center 2006-12-31
NCT00898755 Collecting and Storing Tissue From Young Patients With Cancer https://ClinicalTrials.gov/show/NCT00898755 Completed Children’s Oncology Group 2008-07-17
NCT00885950 Prevention of the Hepatic Sinusoidal Obstruction Syndrome by Means of Anticoagulants https://ClinicalTrials.gov/show/NCT00885950 Completed Maastricht University Medical Center 2009-12-31
NCT00883454 Estimation of Functional Liver Reserve Using Cholinesterases https://ClinicalTrials.gov/show/NCT00883454 Completed University of Milan NA
NCT00875147 Impact of Pre-operative Bevacizumab on Complications After Resection of Colorectal Liver Metastases https://ClinicalTrials.gov/show/NCT00875147 Completed University of Zurich 2009-08-31
NCT00866957 Human Liver Explants for HIF-1 Alpha Analysis/Comparison (HIF HCC) https://ClinicalTrials.gov/show/NCT00866957 Active, not recruiting Northwestern University 2019-07-31
NCT02958592 Assessment of Hepatic Fibrosis by Shear Wave Elastography in Patients With Liver Malignancy: A Prospective Single-center Study https://ClinicalTrials.gov/show/NCT02958592 Completed Sun Yat-sen University 2016-03-31
NCT00836992 Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00836992 Completed Mayo Clinic 2011-09-15
NCT00828607 Contrast Enhanced (CE) Ultrasound and CE Computed Tomography or CE Magnetic Resonance Imaging in Liver Masses https://ClinicalTrials.gov/show/NCT00828607 Completed Foothills Medical Centre 2015-12-31
NCT03896958 The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) https://ClinicalTrials.gov/show/NCT03896958 Recruiting SpeciCare 2021-03-12
NCT00782886 Evaluation of Image-Guided Liver Surgical System for Resection of Liver Cancer https://ClinicalTrials.gov/show/NCT00782886 Completed Pathfinder Therapeutics 2010-11-30
NCT00779272 Impact of Preoperative Chemotherapy on Complications and Regeneration After Resection of Colorectal Liver Metastases https://ClinicalTrials.gov/show/NCT00779272 Completed University of Zurich 2008-10-31
NCT00739167 Quality of Life in Patients Undergoing Embolization Using Yttrium Y 90 Glass Microspheres for Primary or Metastatic Liver Cancer https://ClinicalTrials.gov/show/NCT00739167 Completed Northwestern University 2010-05-31
NCT00728650 A Retrospective Review of Malignant Liver Tumors https://ClinicalTrials.gov/show/NCT00728650 Completed University of Oklahoma 2010-10-31
NCT00681499 Quality of Life After Liver Resection https://ClinicalTrials.gov/show/NCT00681499 Completed University of Bern 2014-01-31
NCT00677781 Impact of Microparticles on Postoperative Complications in Surgical Patients https://ClinicalTrials.gov/show/NCT00677781 Completed University of Bern 2008-12-31
NCT00586235 Registration and Fusion of Real-Time Ultrasound With CT for Lesion Localization and Characterization https://ClinicalTrials.gov/show/NCT00586235 Completed Mayo Clinic 2011-06-30
NCT00532740 Radiolabeled Glass Beads in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT00532740 Recruiting Northwestern University 2021-05-31
NCT00530010 Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT00530010 Recruiting Northwestern University 2024-01-31
NCT00527891 Evaluation of the Signa Excite 3.0 T MRI Excite for Detection and Characterization of Liver Lesions https://ClinicalTrials.gov/show/NCT00527891 Completed M.D. Anderson Cancer Center 2007-09-30
NCT00482586 Quality of Life in Patients With Liver Cancer Treated With Image-Guided Therapy https://ClinicalTrials.gov/show/NCT00482586 Completed Vanderbilt University 2015-04-30
NCT00482365 National Registry and Blood Bank of Patients With Liver Cancer https://ClinicalTrials.gov/show/NCT00482365 Completed Vanderbilt-Ingram Cancer Center 2009-04-30
NCT00408122 Evaluation of Preoperative Investigations in Patients With Liver Cancer https://ClinicalTrials.gov/show/NCT00408122 Completed Odense University Hospital 2012-01-31
NCT00373737 Microarray Analysis of Gene Expression in Liver Tumors https://ClinicalTrials.gov/show/NCT00373737 Completed Stanford University 2008-04-30
NCT00341484 Genetic Susceptibility to Oncogenic Viruses https://ClinicalTrials.gov/show/NCT00341484 Completed National Institutes of Health Clinical Center (CC) 2007-06-05
NCT00310115 Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy https://ClinicalTrials.gov/show/NCT00310115 Completed M.D. Anderson Cancer Center 2016-08-31
NCT00184834 Quality of Life and Liver Metastases https://ClinicalTrials.gov/show/NCT00184834 Completed Radboud University NA
NCT02482259 Assessment of Frailty in Patients With Advanced Hepatocellular Cancers https://ClinicalTrials.gov/show/NCT02482259 Completed Newcastle-upon-Tyne Hospitals NHS Trust 2016-07-19
NCT00002485 Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer https://ClinicalTrials.gov/show/NCT00002485 Completed Children’s Oncology Group 2003-07-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03317483 DEB-TACE Treatment in 367 Liver Cancer Patients https://ClinicalTrials.gov/show/NCT03317483 Completed Zhejiang Cancer Hospital 2016-11-04
NCT03256994 CIRSE Registry for SIR-Spheres in France (CIRT-FR) https://ClinicalTrials.gov/show/NCT03256994 Recruiting Cardiovascular and Interventional Radiological Society of Europe 2020-07-31
NCT02954094 A 5-year Longitudinal Observational Study of the Natural History and Management of Patients With HCC https://ClinicalTrials.gov/show/NCT02954094 Recruiting Target PharmaSolutions, Inc. 2024-10-31
NCT02501980 Hepatocellular Cancer (HCC) Screening in Zhongshan City https://ClinicalTrials.gov/show/NCT02501980 Active, not recruiting Zhongshan People’s Hospital, Guangdong, China 2022-01-31
NCT01891552 Observational Study on Second Line Treatment of Liver Metastases With DEBIRI and Cetuximab https://ClinicalTrials.gov/show/NCT01891552 Completed International Group of Endovascular Oncology 2015-05-31
NCT04274868 Pediatric Hepatic Tumors https://ClinicalTrials.gov/show/NCT04274868 Recruiting Gustave Roussy, Cancer Campus, Grand Paris 2025-09-30
NCT04075305 The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study https://ClinicalTrials.gov/show/NCT04075305 Recruiting UMC Utrecht 2024-02-01
NCT03563274 QuiremSpheres Observational Study https://ClinicalTrials.gov/show/NCT03563274 Recruiting Terumo Europe N.V. 2021-05-31
NCT03452774 SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry https://ClinicalTrials.gov/show/NCT03452774 Recruiting Massive Bio, Inc. 2021-12-31